Header Logo

HASHEM EL-SERAG

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address7200 CAMBRIDGE
vCardDownload vCard
    Other Positions
    TitleChair
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine


    Collapse Biography 
    Collapse awards and honors
    1985 - 1990The “Medical University Award”
    1999Department of Veterans Affairs “Special Contribution Award” for published research on hepatocellular
    1999Research mentor Award, University of New Mexico
    2001The American Digestive Health Foundation Research Award
    2001The American College of Gastroenterology Research Award
    2002Gastroenterology Research Group (GRG) Young Clinical Investigator Award
    2003John M. Eisenberg Memorial Lectureship on Therapeutics Research
    2003The American Society for Gastrointestinal Endoscopy Research Award
    2003The American Gastroenterological Association’s representative to the Japan AGA/GRG Symposium
    2006The American College of Gastroenterology Research Award
    2006The American Gastroenterological Association’s Master’s Award in Clinical Research
    2008American Society for Clinical Investigators (ASCI)
    2009 - 2011Best Doctors in America®
    2009 - 2011Houston’s Best Doctors
    2010Charles Mörtel Lecture, International Cancer Society
    2011Texas Super Doctors
    2011Blue Faery Award for Excellence in Liver Cancer Research

    Collapse Overview 
    Collapse overview
    Clinical Interests

    Barrett's esophagus, gastroesophageal reflux disease (GERD), dyspepsia, irritable bowel syndrome (IBS), celiac disease, colonoscopy, esophagogastroduodenoscopy (EGD), bravo pH monitoring, chronic liver disease, and liver cancer

    Collapse Research 
    Collapse research activities and funding
    I01HX003655     (EL-SERAG, HASHEM B)Feb 1, 2024 - Jan 31, 2028
    NIH
    Testing the Effectiveness of NAFLD Clinical Care Pathway in VA Primary Care
    Role: Principal Investigator
    P01CA263025     (EL-SERAG, HASHEM B)Jul 1, 2022 - Jun 30, 2027
    NIH
    Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
    Role: Principal Investigator
    U01CA230997     (KANWAL, FASIHA)Sep 13, 2018 - Aug 31, 2028
    NIH
    Risk Stratification for and Early Detection of Liver Cancer
    Role: Co-Principal Investigator
    I01CX001616     (EL-SERAG, HASHEM B)Oct 1, 2017 - Sep 30, 2021
    NIH
    PREVALENCE AND PREDICTORS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN VETERANS
    Role: Principal Investigator
    R01CA190776     (EL-SERAG, HASHEM B)Feb 12, 2015 - Jan 31, 2020
    NIH
    A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
    Role: Principal Investigator
    RC4CA155844     (EL-SERAG, HASHEM B)Sep 30, 2010 - Sep 30, 2013
    NIH
    Comparative Effectiveness of Screening and Surveillance Endoscopy
    Role: Principal Investigator
    T32DK083266     (KANWAL, FASIHA)Mar 1, 2009 - Apr 30, 2025
    NIH
    Research Training in Gastroenterology
    Role: Principal Investigator
    R01CA125487     (EL-SERAG, HASHEM B)Sep 17, 2007 - Aug 31, 2010
    NIH
    Surveillance for Hepatocellular Carcinoma among HCV-infected Veterans
    Role: Principal Investigator
    K24DK078154     (EL-SERAG, HASHEM B)May 1, 2007 - Apr 30, 2018
    NIH
    Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program
    Role: Principal Investigator
    R01CA116845     (EL-SERAG, HASHEM B)Apr 1, 2007 - Jan 31, 2013
    NIH
    Obesity, H pylori and Risk of Barrett's Esophagus
    Role: Principal Investigator
    R21DK067366     (EL-SERAG, HASHEM B)Aug 1, 2005 - Dec 31, 2007
    NIH
    Gene Expression in Barrett's Esophagus
    Role: Principal Investigator
    P30DK056338     (EL-SERAG, HASHEM B)Dec 1, 1999 - May 31, 2028
    NIH
    Texas Medical Center Digestive Diseases Center
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Khalaf N, Ali B, Zimolzak AJ, Liu Y, Kramer JR, El-Serag HB, Kanwal F, Singh H. Prevalence and Outcomes of Emergency Presentations of Colorectal Cancer in Veterans Affairs Health Care System. Dig Dis Sci. 2024 Dec 11. PMID: 39661278.
      Citations:    
    2. Liu KS, George R, Shin C, Xiong JQ, Jamali T, Liu Y, Roy P, Singh S, Ma S, El-Serag HB, Tan MC. Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test. Dig Dis Sci. 2024 Nov 24. PMID: 39581897.
      Citations:    Fields:    
    3. Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y, Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y. Phase 3 Validation of Prognostic Liver Secretome Signature With a-Fetoprotein Plus Age, Male Sex, Albumin-Bilirubin, and Platelets for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. Gastroenterology. 2024 Nov 08. PMID: 39521255.
      Citations:    Fields:    
    4. Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323. PMID: 39283612; PMCID: PMC11406452.
      Citations: 1     Fields:    Translation:Humans
    5. Saab O, Al-Obaidi H, Merza N, Bhagat U, Al-Sagban A, Algodi M, Abuelazm M, El-Serag H. The Impact of Visual Distraction Interventions on Patients' Pain and Anxiety During Colonoscopy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Gastroenterol. 2024 Oct 29. PMID: 39495815.
      Citations:    Fields:    
    6. El-Serag HB, Thrift AP, Duong H, Ning J, Khaderi S, Singal AG, Asrani SK, Marrero JA, Powell H, Rizwan K, Najjar O, Amos CI, Luster M, Al-Sarraj A, Salem E, Scheurer ME, Chhatwal J, Kaochar S, Kanwal F. Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11). PMID: 39652379; PMCID: PMC11469875.
      Citations:    
    7. Dinis-Ribeiro M, Shah S, El-Serag H, Banks M, Uedo N, Tajiri H, Coelho LG, Libanio D, Lahner E, Rollan A, Fang JY, Moreira L, Bornschein J, Malfertheiner P, Kuipers EJ, El-Omar EM. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut. 2024 Sep 09; 73(10):1607-1617. PMID: 39122364.
      Citations: 1     Fields:    Translation:HumansCells
    8. Khalaf N, Liu Y, Kramer JR, El-Serag HB, Kanwal F, Singh H, Khalaf N, Liu Y, Kramer JR, El-Serag HB, Kanwal F, Singh H, Khalaf N. Defining and Understanding Diagnostic Delays Among Pancreatic Cancer Patients: A Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2024 Jul 27. PMID: 39074521.
      Citations:    Fields:    
    9. Ma S, Alsabawi Y, El-Serag HB, Thrift AP. Exposure to Light at Night and Risk of Cancer: A Systematic Review, Meta-Analysis, and Data Synthesis. Cancers (Basel). 2024 Jul 26; 16(15). PMID: 39123381; PMCID: PMC11311462.
      Citations: 1     
    10. El-Serag HB, Jin Q, Nabihah T, Salem E, Luster M, Alsarraj A, Khaderi S, Singal AG, Marrero JA, Asrani SK, Kanwal F, El-Serag HB, Tayob N, Alsarraj A, Singal AG, Marrero JA, Asrani SK. HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology. 2024 Jun 19. PMID: 38899967.
      Citations: 1     Fields:    
    11. Thrift AP, Kanwal F, Lim H, Duong H, Liu Y, Singal AG, Khaderi S, Asrani SK, Amos CI, El-Serag HB, Thrift AP, Kanwal F, Lim H, Duong H, Liu Y, Singal AG, Khaderi S, Asrani SK, Amos CI, El-Serag HB. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024 Sep; 22(9):1858-1866.e4. PMID: 38729396; PMCID: PMC11615715.
      Citations: 1     Fields:    Translation:Humans
    12. Thrift AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, Duong HT, Loomba R, Kanwal F, El-Serag HB. An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Dig Dis Sci. 2024 Jul; 69(7):2430-2436. PMID: 38700632; PMCID: PMC11258165.
      Citations: 1     Fields:    Translation:Humans
    13. Rugge M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, El-Serag H, Graham DY, Kuipers EJ, Leung WK, Park JY, Rokkas T, Schulz C, El-Omar EM, RE.GA.IN, RE GA IN. RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024 02 23; 73(3):407-441. PMID: 38383142.
      Citations: 4     Fields:    Translation:HumansCells
    14. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI, Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 07 01; 80(1):87-101. PMID: 38381705; PMCID: PMC11191046.
      Citations: 2     Fields:    Translation:Humans
    15. El-Serag H, Kanwal F, Ning J, Powell H, Khaderi S, Singal AG, Asrani S, Marrero JA, Amos CI, Thrift AP, Luster M, Alsarraj A, Olivares L, Skapura D, Deng J, Salem E, Najjar O, Yu X, Duong H, Scheurer ME, Ballantyne CM, Kaochar S. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut. 2024 Feb 16. PMID: 38365278; PMCID: PMC11327383.
      Citations: 3     Fields:    
    16. Thomas JA, Kendall BJ, El-Serag HB, Thrift AP, Macdonald GA. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2024 Feb; 9(2):159-169. PMID: 38215780.
      Citations: 7     Fields:    Translation:Humans
    17. Liu KS, Raza SA, El-Serag HB, Thrift AP. Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45. PMID: 36413030; PMCID: PMC10199958.
      Citations: 2     Fields:    
    18. Khalaf N, Ali B, Liu Y, Kramer JR, El-Serag H, Kanwal F, Singh H. Emergency Presentations Predict Worse Outcomes Among Patients with Pancreatic Cancer. Dig Dis Sci. 2024 Feb; 69(2):603-614. PMID: 38103105.
      Citations: 1     Fields:    Translation:Humans
    19. Alizadeh M, Schledwitz A, Patil SA, El-Serag H, Ravel J, Sampaio Moura N, Raufman JP. A Practical Guide to Evaluating and Using Big Data in Digestive Disease Research. Gastroenterology. 2024 02; 166(2):240-247. PMID: 38052336; PMCID: PMC10872385.
      Citations:    Fields:    Translation:Humans
    20. Khalaf N, Xu A, Nguyen Wenker T, Kramer JR, Liu Y, Singh H, El-Serag HB, Kanwal F. The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Pancreas. 2024 Jan 01; 53(1):e27-e33. PMID: 37967826; PMCID: PMC10883640.
      Citations:    Fields:    Translation:Humans
    21. Oluyomi AO, Thrift AP, Olayode A, Symanski E, Roy H, El-Serag HB. Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study. Environ Res. 2024 Jan 01; 240(Pt 2):117538. PMID: 37926230.
      Citations:    Fields:    Translation:Humans
    22. Moss SF, Shah SC, Tan MC, El-Serag HB. Evolving Concepts in Helicobacter pylori Management. Gastroenterology. 2024 02; 166(2):267-283. PMID: 37806461; PMCID: PMC10843279.
      Citations: 1     Fields:    Translation:HumansCells
    23. Sonnenberg A, Duong HT, McCarty DJ, El-Serag HB. Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2023 12 01; 35(12):1349-1353. PMID: 37942756.
      Citations:    Fields:    Translation:Humans
    24. El-Serag HB, Akhdar G, Thrift AP, Luster M, Khaderi S, Alsarraj A, Duong H, Kanwal F. Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study. Hepatol Commun. 2023 10 01; 7(10). PMID: 37695087; PMCID: PMC10497244.
      Citations:    Fields:    Translation:Humans
    25. Khalaf N, Kramer J, Liu Y, Abrams D, Singh H, El-Serag H, Kanwal F. Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Dig Dis Sci. 2023 09; 68(9):3634-3643. PMID: 37474717.
      Citations:    Fields:    Translation:Humans
    26. Jacob J, Millien V, Berger S, Hernaez R, Ketwaroo GA, Flores AG, Hou JK, Jarbrink-Sehgal ME, Khalaf NI, Rosen DG, El-Serag HB, Tan MC. Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):432-439. PMID: 37436841; PMCID: PMC10787041.
      Citations:    Fields:    
    27. Pan S, Thrift AP, Akhdar G, El-Serag HB. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies. Dig Dis Sci. 2023 09; 68(9):3732-3744. PMID: 37432532.
      Citations:    Fields:    Translation:Humans
    28. Heredia NI, Thrift AP, Ramsey DJ, Loomba R, El-Serag HB. Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary Care. Nutrients. 2023 Jun 01; 15(11). PMID: 37299561; PMCID: PMC10255737.
      Citations:    Fields:    Translation:Humans
    29. Kligman E, Tan MC, Sen A, Othman MO, Liu Y, El-Serag HB, Thrift AP. Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023 10; 98(4):569-576.e1. PMID: 37207845; PMCID: PMC10524993.
      Citations: 1     Fields:    Translation:HumansCells
    30. El-Serag H, Ioannou GN, Singal AG, Block T, McMahon B, Cohen C, Brown RS, Lok AS, Roberts LR. Opportunities to address gaps in early detection and improve outcomes of liver cancer. JNCI Cancer Spectr. 2023 05 02; 7(3). PMID: 37144952; PMCID: PMC10212536.
      Citations:    Fields:    Translation:Humans
    31. Kanwal F, Khaderi S, Singal AG, Marrero JA, Asrani SK, Amos CI, Thrift AP, Kramer JR, Yu X, Cao Y, Luster M, Al-Sarraj A, Ning J, El-Serag HB. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3. PMID: 37390101; PMCID: PMC10661677.
      Citations:    Fields:    Translation:Humans
    32. El-Serag HB, Ward JW, Asrani SK, Singal AG, Rich N, Thrift AP, Deshpande S, Turner BJ, Kaseb AO, Harrison AC, Fortune BE, Kanwal F. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. Clin Gastroenterol Hepatol. 2023 08; 21(9):2183-2192. PMID: 37086825; PMCID: PMC10524305.
      Citations:    Fields:    Translation:Humans
    33. Dai A, Hoffman K, Xu AA, Gurwara S, White DL, Kanwal F, Jang A, El-Serag HB, Petrosino JF, Jiao L. The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Preliminary Investigation. Nutrients. 2023 Apr 03; 15(7). PMID: 37049587; PMCID: PMC10096519.
      Citations: 1     Fields:    Translation:Humans
    34. Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023 05; 20(5):338-349. PMID: 36959359.
      Citations: 17     Fields:    Translation:HumansCells
    35. Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenw?lder M, El-Serag HB, Finn RS, Friedman SL. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023 08; 20(8):487-503. PMID: 36932227.
      Citations: 8     Fields:    Translation:Humans
    36. Thrift AP, Kanwal F, Liu Y, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Luster M, Al-Sarraj A, Ning J, Tsavachidis S, Gu X, Amos CI, El-Serag HB. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309. PMID: 36854015; PMCID: PMC9974109.
      Citations: 1     Fields:    Translation:Humans
    37. Kanwal F, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Amos CI, Thrift AP, Gu X, Luster M, Al-Sarraj A, Ning J, El-Serag HB. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005. PMID: 35229329; PMCID: PMC9433461.
      Citations:    Fields:    
    38. Spechler SJ, El-Serag HB. Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma? Am J Gastroenterol. 2023 04 01; 118(4):590-592. PMID: 36728873.
      Citations: 2     Fields:    Translation:Humans
    39. Liu KS, Raza SA, El-Serag HB, Thrift AP. Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019. Cancers (Basel). 2022 Dec 08; 14(24). PMID: 36551535; PMCID: PMC9775957.
      Citations: 1     
    40. Cholankeril G, Kramer JR, Chu J, Yu X, Balakrishnan M, Li L, El-Serag HB, Kanwal F. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500. PMID: 36402450; PMCID: PMC10661838.
      Citations: 6     Fields:    Translation:Humans
    41. Bj?rn? ER, Engelsen MT, El-Serag HB, Ness-Jensen E. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scand J Gastroenterol. 2023 05; 58(5):505-511. PMID: 36314512.
      Citations:    Fields:    Translation:Humans
    42. Nguyen Wenker T, Peng FB, Emelogu I, Mallepally N, Kanwal F, El-Serag HB, Tan MC. The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1771-1780. PMID: 36270616; PMCID: PMC10110767.
      Citations:    Fields:    Translation:HumansCells
    43. Holmberg D, Mattsson F, Xie S, Ness-Jensen E, El-Serag H, Lagergren J. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy. J Gastroenterol. 2022 12; 57(12):942-951. PMID: 36258093; PMCID: PMC9663349.
      Citations:    Fields:    Translation:Humans
    44. Chen B, Tang WHW, Rodriguez M, Corey KE, Sanyal AJ, Kamath PS, Bozkurt B, Virk HUH, Pressman GS, Lazarus JV, El-Serag HB, Krittanawong C. NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? Semin Liver Dis. 2022 11; 42(4):465-474. PMID: 36241194.
      Citations: 2     Fields:    Translation:Humans
    45. Cholankeril G, El-Serag HB. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2023 02; 43(1):89-99. PMID: 36216350.
      Citations: 1     Fields:    Translation:Humans
    46. Kim HS, Xiao X, Byun J, Jun G, DeSantis SM, Chen H, Thrift AP, El-Serag HB, Kanwal F, Amos CI. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. JAMA Netw Open. 2022 10 03; 5(10):e2234221. PMID: 36190732; PMCID: PMC9530967.
      Citations: 3     Fields:    Translation:Humans
    47. Jacobs G, Boyle DA, El-Serag HB, Lewandowski RJ, Stein SM, Lazure P, McFadden P. Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals. Cancer Med. 2023 02; 12(3):3670-3683. PMID: 36106593; PMCID: PMC9939175.
      Citations:    
    48. Nguyen Wenker T, Natarajan Y, Caskey K, Novoa F, Mansour N, Pham HA, Hou JK, El-Serag HB, Thrift AP. Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett's Esophagus. Clin Gastroenterol Hepatol. 2023 05; 21(5):1198-1204. PMID: 36115659; PMCID: PMC10014472.
      Citations:    
    49. Wenker TN, Thrift AP, El-Serag HB. Limits of the AGA Practice Update for Barrett's Esophagus Screening: A Proposal for Electronic Health Record-Adaptable Risk Models. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1963-1964. PMID: 36087710.
      Citations:    
    50. Kramer JR, Cao Y, Li L, Smith D, Chhatwal J, El-Serag HB, Kanwal F. Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection. Am J Gastroenterol. 2022 11 01; 117(11):1834-1844. PMID: 36327437; PMCID: PMC9641546.
      Citations: 1     Fields:    Translation:HumansCells
    51. Harrison AC, Kanwal F, Asrani SK, Thrift AP, Amos CI, Jibaja-Weiss ML, Montealegre JR, Hwang JP, Singal AG, El-Serag HB. The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy. Front Oncol. 2022; 12:953933. PMID: 36059708; PMCID: PMC9437299.
      Citations:    
    52. Wenker TN, Rubenstein JH, Thrift AP, Singh H, El-Serag HB. Development and Validation of the Houston-BEST, a Barrett's Esophagus Risk Prediction Model Adaptable to Electronic Health Records. Clin Gastroenterol Hepatol. 2023 08; 21(9):2424-2426.e0. PMID: 35985640; PMCID: PMC9935746.
      Citations:    
    53. Thrift AP, Liu KS, Raza SA, El-Serag HB. Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States. Clin Gastroenterol Hepatol. 2023 08; 21(9):2418-2420.e3. PMID: 35944829.
      Citations:    
    54. Oluyomi AO, El-Serag HB, Olayode A, Thrift AP. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas. Clin Gastroenterol Hepatol. 2023 05; 21(5):1314-1322.e5. PMID: 35933074; PMCID: PMC9898456.
      Citations:    
    55. Goff C, Shaikh A, Goli K, El-Serag HB, Kanwal F, Cholankeril G, Liver Cancer Investigator Working Group. Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1. PMID: 35870770; PMCID: PMC10601142.
      Citations:    Fields:    
    56. Thrift AP, Nguyen TH, Pham C, Balakrishnan M, Kanwal F, Loomba R, Duong HT, Ramsey D, El-Serag HB. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2023 05; 21(5):1252-1260.e5. PMID: 35811043; PMCID: PMC9825675.
      Citations:    Fields:    
    57. Natarajan Y, Patel P, Chu J, Yu X, Hernaez R, El-Serag H, Kanwal F. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Dig Dis Sci. 2023 01; 68(1):312-322. PMID: 35790703.
      Citations: 1     Fields:    
    58. Oluyomi AO, Mohammadi KA, El-Serag HB, Thrift AP. Mediating Effects of Neighborhood-Level Socioeconomic Deprivation on the Association Between Race/Ethnicity and Advanced Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2022 07 01; 31(7):1402-1409. PMID: 35314860; PMCID: PMC9661396.
      Citations:    Fields:    Translation:Humans
    59. Xu AA, Kennedy LK, Hoffman K, White DL, Kanwal F, El-Serag HB, Petrosino JF, Jiao L. Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans. Nutrients. 2022 Jun 29; 14(13). PMID: 35807903; PMCID: PMC9268849.
      Citations:    Fields:    Translation:HumansAnimalsCells
    60. Chu J, Cholankeril G, Yu X, Rana A, Natarajan Y, El-Serag HB, Kramer J, Kanwal F. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070. PMID: 35759159; PMCID: PMC9792631.
      Citations:    Fields:    
    61. Eslam M, El-Serag HB, Francque S, Sarin SK, Wei L, George J, Bugianesi E. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022 10; 19(10):638-651. PMID: 35710982.
      Citations:    Fields:    
    62. Tan MC, Mallepally N, Nguyen TH, Hammad T, Kim DK, Othman MO, El-Serag HB, Thrift AP. Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma. Dig Dis Sci. 2023 03; 68(3):761-769. PMID: 35689702.
      Citations:    Fields:    
    63. Kim HS, Shetty PB, Tsavachidis S, Dong J, Amos CI, El-Serag HB, Thrift AP. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis. Clin Gastroenterol Hepatol. 2023 04; 21(4):1023-1030.e39. PMID: 35680035; PMCID: PMC9722981.
      Citations:    Fields:    
    64. Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022 07 05; 34(7):969-977.e2. PMID: 35793659; PMCID: PMC9762323.
      Citations:    Fields:    Translation:Humans
    65. Tan MC, El-Serag HB, Thrift AP. Response to Swami et al. Am J Gastroenterol. 2022 06 01; 117(6):1012. PMID: 35665704; PMCID: PMC9179085.
      Citations:    Fields:    
    66. Jove AG, Holmes HM, Tan MC, El-Serag HB, Thrift AP. Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia. Clin Gastroenterol Hepatol. 2023 01; 21(1):64-71. PMID: 35569739; PMCID: PMC9653509.
      Citations:    Fields:    
    67. Kramer JR, Natarajan Y, Dai J, Yu X, Li L, El-Serag HB, Kanwal F. Reply. Hepatology. 2022 Aug; 76(2):E50. PMID: 35366357.
      Citations:    Fields:    
    68. Heredia NI, Gaba R, Liu Y, Jain S, Rungta M, Rungta M, El-Serag HB, Kanwal F, Thrift AP, Balakrishnan M. Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease. Sci Rep. 2022 04 05; 12(1):5695. PMID: 35383229; PMCID: PMC8983643.
      Citations:    Fields:    Translation:Humans
    69. Thakur ER, Shapiro J, Chan J, Lumley MA, Cully JA, Bradford A, El-Serag HB. Correction to: A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study. Dig Dis Sci. 2022 Apr; 67(4):1427. PMID: 35274216.
      Citations:    Fields:    
    70. Kramer JR, Richardson PA, Kim H, Hsu YC, Kanwal F, El-Serag HB. The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. Clin Gastroenterol Hepatol. 2023 04; 21(4):1111-1113.e3. PMID: 35276326; PMCID: PMC9452600.
      Citations:    Fields:    
    71. Kim HS, Hernaez R, Sansgiry S, Waljee AK, Scott FI, Lewis JD, El-Serag HB, Hou JK. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 12; 20(12):2848-2857.e2. PMID: 35240331; PMCID: PMC9489337.
      Citations:    Fields:    
    72. Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4. PMID: 35124267; PMCID: PMC9346092.
      Citations: 1     Fields:    
    73. Tan MC, Jamali T, Nguyen TH, Galvan A, Sealock RJ, Khan A, Zarrin-Khameh N, Holloman A, Kampagianni O, Ticas DH, Liu Y, El-Serag HB, Thrift AP. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol. 2022 02 01; 117(2):280-287. PMID: 34908535; PMCID: PMC8816815.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    74. Khalaf N, Abrams HR, Eke C, Kanwal F, El-Serag HB. Why Do Small Intraductal Papillary Mucinous Neoplasms Create Such a Huge Management Challenge?: How International Classification of Diseases Codes Have Failed Us. Pancreas. 2022 02 01; 51(2):e13-e15. PMID: 35404900; PMCID: PMC10127940.
      Citations:    Fields:    Translation:Humans
    75. Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. Am J Drug Alcohol Abuse. 2022 07 04; 48(4):445-453. PMID: 35077656.
      Citations:    Fields:    
    76. Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc. 2022 06; 95(6):1113-1122. PMID: 34998796; PMCID: PMC9119926.
      Citations:    Fields:    Translation:Humans
    77. Thrift AP, Jove AG, Liu Y, Tan MC, El-Serag HB. Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol. 2022 01 01; 56(1):e71-e76. PMID: 33337636; PMCID: PMC8875544.
      Citations: 2     Fields:    Translation:HumansCells
    78. Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling AM, Tapper EB. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 05; 75(5):1289-1299. PMID: 34778999.
      Citations: 1     Fields:    Translation:Humans
    79. Kramer JR, Natarajan Y, Dai J, Yu X, Li L, El-Serag HB, Kanwal F. Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology. 2022 06; 75(6):1420-1428. PMID: 34779535; PMCID: PMC9107529.
      Citations: 2     Fields:    Translation:Humans
    80. Singal AG, Tayob N, Mehta A, Marrero JA, El-Serag H, Jin Q, Saenz de Viteri C, Fobar A, Parikh ND. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. Hepatology. 2022 03; 75(3):541-549. PMID: 34618932; PMCID: PMC8844059.
      Citations: 6     Fields:    Translation:Humans
    81. Tan MC, Ho Q, Nguyen TH, Liu Y, El-Serag HB, Thrift AP. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Dig Dis Sci. 2022 09; 67(9):4500-4508. PMID: 34797447; PMCID: PMC9117573.
      Citations: 2     Fields:    
    82. Holmes HM, Jove AG, Tan MC, El-Serag HB, Thrift AP. Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population. PLoS One. 2021; 16(11):e0260019. PMID: 34780551; PMCID: PMC8592489.
      Citations:    Fields:    Translation:Humans
    83. Natarajan Y, El-Serag HB. Risk Factors for Hepatocellular Carcinoma: A Historical Perspective. Clin Liver Dis (Hoboken). 2021 Oct; 18(Suppl 1):1-13. PMID: 34745580; PMCID: PMC8555458.
      Citations:    
    84. Vajravelu RK, Shapiro JM, El-Serag HB. Reply. Clin Gastroenterol Hepatol. 2022 09; 20(9):2149. PMID: 34715380.
      Citations: 1     Fields:    
    85. Engels MM, Glicksberg BS, Johnson KW, Mzaik O, van Hooft JE, Wallace MB, El-Serag HB, Krittanawong C, Kr?ner PT. Artificial intelligence in gastroenterology: A state-of-the-art review. World J Gastroenterol. 2021 Oct 28; 27(40):6794-6824. PMID: 34790008; PMCID: PMC8567482.
      Citations: 2     Fields:    Translation:Humans
    86. Kim HS, Yu X, Kramer J, Thrift AP, Richardson P, Hsu YC, Flores A, El-Serag HB, Kanwal F. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. J Hepatol. 2022 02; 76(2):294-301. PMID: 34563579; PMCID: PMC8786210.
      Citations:    Fields:    Translation:HumansPHPublic Health
    87. Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, Abdelmalek MF, Harrison SA, Loomba R, Mantzoros CS, Bugianesi E, Eckel RH, Kaplan LM, El-Serag HB, Cusi K. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2021 11; 161(5):1657-1669. PMID: 34602251; PMCID: PMC8819923.
      Citations: 10     Fields:    Translation:Humans
    88. Singal AG, El-Serag HB. Rational HCC screening approaches for patients with NAFLD. J Hepatol. 2022 01; 76(1):195-201. PMID: 34508791; PMCID: PMC8688224.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    89. Vajravelu RK, Shapiro JM, Ni J, Thanawala SU, Lewis JD, El-Serag HB. Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1305-e1322. PMID: 34481956; PMCID: PMC8891390.
      Citations:    Fields:    Translation:Humans
    90. Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, Eckel RH, Kruger D, El-Serag H, Cusi K. Preparing for the NASH epidemic: A call to action. Obesity (Silver Spring). 2021 09; 29(9):1401-1412. PMID: 34365735.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    91. Natarajan Y, Tansel A, Patel P, Emelogu IK, Shukla R, Qureshi Z, El-Serag HB, Thrift AP, Kanwal F. Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2021 Aug; 66(8):2842. PMID: 32990866.
      Citations: 1     Fields:    
    92. Fass R, Boeckxstaens GE, El-Serag H, Rosen R, Sifrim D, Vaezi MF. Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 07 29; 7(1):55. PMID: 34326345.
      Citations: 1     Fields:    Translation:Humans
    93. Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, Eckel RH, Kruger D, El-Serag H, Cusi K. Preparing for the NASH Epidemic: A Call to Action. Diabetes Care. 2021 09; 44(9):2162-2172. PMID: 34312182.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    94. Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, Eckel RH, Kruger D, El-Serag H, Cusi K. Preparing for the NASH Epidemic: A Call to Action. Gastroenterology. 2021 09; 161(3):1030-1042.e8. PMID: 34416976.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    95. Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, Eckel RH, Kruger D, El-Serag H, Cusi K. Preparing for the NASH epidemic: A call to action. Metabolism. 2021 09; 122:154822. PMID: 34289945.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    96. Montealegre JR, Singal AG, Asrani SK, El-Serag H, Montealegre et al. A Conceptual Model for Implementation and Evaluation of Interventions Across the Hepatocellular Carcinoma Care Continuum. Clin Gastroenterol Hepatol. 2022 05; 20(5):1174-1176. PMID: 34274512.
      Citations:    Fields:    Translation:HumansPHPublic Health
    97. Jiao L, Kourkoumpetis T, Hutchinson D, Ajami NJ, Hoffman K, White DL, Graham DY, Hair C, Shah R, Kanwal F, Jarbrink-Sehgal M, Husain N, Hernaez R, Hou J, Cole R, Velez M, Ketwaroo G, Kramer J, El-Serag HB, Petrosino JF. Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans. Microb Ecol. 2022 Apr; 83(3):811-821. PMID: 34223947.
      Citations: 1     Fields:    Translation:HumansCells
    98. Agrawal R, Ajami NJ, Malhotra S, Chen L, White DL, Sharafkhaneh A, Hoffman KL, Graham DY, El-Serag HB, Petrosino JF, Jiao L. Habitual Sleep Duration and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Pilot Study. Clocks Sleep. 2021 Jul 01; 3(3):387-397. PMID: 34287254; PMCID: PMC8293063.
      Citations: 4     
    99. Kanwal F, El-Serag HB. Presentation of the AGA William Beaumont Prize in Gastroenterology to David Y. Graham, MD. Gastroenterology. 2021 07; 161(1):333-335. PMID: 34048751.
      Citations:    Fields:    Translation:Humans
    100. El-Serag H. Our New President-John M. Inadomi, MD, AGAF. Gastroenterology. 2021 05; 160(6):2149-2154. PMID: 33933192.
      Citations:    Fields:    
    101. Nguyen TH, Thrift AP, George R, Rosen DG, El-Serag HB, Ketwaroo GA. Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population. Clin Gastroenterol Hepatol. 2022 04; 20(4):e876-e889. PMID: 33839273; PMCID: PMC8900254.
      Citations: 1     Fields:    Translation:Humans
    102. Khan IM, Gjuka D, Jiao J, Song X, Wang Y, Wang J, Wei P, El-Serag HB, Marrero JA, Beretta L. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674. PMID: 33685927; PMCID: PMC8225562.
      Citations: 2     Fields:    Translation:Humans
    103. Zhang X, El-Serag HB, Thrift AP. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control. 2021 Apr; 32(4):317-325. PMID: 33394207.
      Citations: 4     Fields:    Translation:Humans
    104. Kim HS, El-Serag HB. Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?-Still an unsolved question. Hepatobiliary Surg Nutr. 2021 Jan; 10(1):119-122. PMID: 33575300; PMCID: PMC7867738.
      Citations:    
    105. Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021 04; 18(4):223-238. PMID: 33349658; PMCID: PMC8016738.
      Citations: 154     Fields:    Translation:Humans
    106. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021 01; 73 Suppl 1:4-13. PMID: 32319693; PMCID: PMC7577946.
      Citations: 207     Fields:    Translation:Humans
    107. Kanwal F, Taylor TJ, Kramer JR, Cao Y, Smith D, Gifford AL, El-Serag HB, Naik AD, Asch SM. Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality. JAMA Netw Open. 2020 11 02; 3(11):e2023780. PMID: 33141161; PMCID: PMC7610191.
      Citations: 6     Fields:    Translation:Humans
    108. Moayyedi P, El-Serag HB. Current Status of Chemoprevention in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):117-130. PMID: 33213791.
      Citations: 3     Fields:    Translation:Humans
    109. Natarajan Y, Kramer JR, Yu X, Li L, Thrift AP, El-Serag HB, Kanwal F. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. Hepatology. 2020 10; 72(4):1242-1252. PMID: 32022277; PMCID: PMC8318072.
      Citations: 15     Fields:    Translation:Humans
    110. Shapiro JM, Himes R, Khaderi S, Economides J, El-Serag HB. A multidisciplinary approach to improving transition readiness in pediatric liver transplant recipients. Pediatr Transplant. 2021 03; 25(2):e13839. PMID: 32997866.
      Citations:    Fields:    Translation:Humans
    111. Rugge M, Sacchi D, Genta RM, Zanco F, Guzzinati S, Pizzi M, Fassan M, Di Sabatino A, El-Serag H. Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. Dig Liver Dis. 2021 01; 53(1):61-65. PMID: 33004294.
      Citations: 2     Fields:    Translation:Humans
    112. Xu AA, Hoffman K, Gurwara S, White DL, Kanwal F, El-Serag HB, Petrosino JF, Jiao L. Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota. Dig Dis Sci. 2021 09; 66(9):2981-2991. PMID: 32974807; PMCID: PMC7987909.
      Citations: 1     Fields:    Translation:Humans
    113. Graham DY, El-Serag HB. European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners. Gut. 2021 01; 70(1):1-2. PMID: 32958543; PMCID: PMC10506726.
      Citations: 5     Fields:    Translation:HumansCells
    114. Gurwara S, Dai A, Ajami NJ, Graham DY, White DL, Chen L, Jang A, Chen E, El-Serag HB, Petrosino JF, Jiao L. Alcohol use alters the colonic mucosa-associated gut microbiota in humans. Nutr Res. 2020 11; 83:119-128. PMID: 33096423; PMCID: PMC7669629.
      Citations: 6     Fields:    Translation:HumansCells
    115. Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 08 20; 26(9):1423-1428. PMID: 31728520; PMCID: PMC7441098.
      Citations: 7     Fields:    Translation:Humans
    116. Reader SW, Kim HS, El-Serag HB, Thrift AP. Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System. Open Forum Infect Dis. 2020 Aug; 7(8):ofaa322. PMID: 32875004; PMCID: PMC7452366.
      Citations: 1     
    117. Tayob N, Corley DA, Christie I, Almers L, Rahal AK, Richardson P, White DL, Davila J, Kanwal F, El-Serag HB. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. Clin Gastroenterol Hepatol. 2021 07; 19(7):1443-1450.e6. PMID: 32768590; PMCID: PMC8201947.
      Citations: 7     Fields:    Translation:Humans
    118. Balakrishnan M, Seth A, Cortes-Santiago N, Jain S, Sood GK, El-Serag HB, Thrift AP. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393. PMID: 32757159.
      Citations: 2     Fields:    Translation:Humans
    119. Natarajan Y, Tansel A, Patel P, Emologu K, Shukla R, Qureshi Z, El-Serag HB, Thrift AP, Kanwal F. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2021 07; 66(7):2439-2451. PMID: 32743773.
      Citations: 5     Fields:    Translation:Humans
    120. Choi DT, Davila JA, Sansgiry S, David E, Singh H, El-Serag HB, Sada YH. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 08; 19(8):1679-1687. PMID: 32693047; PMCID: PMC7855025.
      Citations: 4     Fields:    Translation:Humans
    121. Khalaf N, El-Serag H, Kanwal F, Chan J. The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes. Gastroenterology. 2020 09; 159(3):1184-1185. PMID: 32681921.
      Citations:    Fields:    
    122. Siddique SM, Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Falck-Ytter Y, El-Serag HB, AGA. Spotlight: COVID-19 PPE and Endoscopy. Gastroenterology. 2020 Aug; 159(2):759. PMID: 32590006; PMCID: PMC7309779.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    123. Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett's esophagus and performance of societal?screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021 02; 93(2):409-419.e1. PMID: 32565183; PMCID: PMC7749069.
      Citations: 3     Fields:    Translation:Humans
    124. Wang Z, El-Serag HB, Thrift AP. Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci. 2021 05; 66(5):1669-1672. PMID: 32548813.
      Citations: 3     Fields:    Translation:Humans
    125. Tan MC, Mallepally N, Ho Q, Liu Y, El-Serag HB, Thrift AP. Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610. PMID: 32535778; PMCID: PMC8845052.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    126. Hernaez R, Liu Y, Kramer JR, Rana A, El-Serag HB, Kanwal F. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433. PMID: 32531416; PMCID: PMC10424237.
      Citations: 18     Fields:    Translation:Humans
    127. Kim HS, Guerrero R, Reader SW, Daheri M, Balakrishnan M, Troisi CL, El-Serag HB, Thrift AP. Low Yield of Hepatitis C Infection in an Outreach Screening Program in Harris County, Texas. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa191. PMID: 32665957; PMCID: PMC7336547.
      Citations:    
    128. Gantuya B, El-Serag HB, Yamaoka Y. Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply. Aliment Pharmacol Ther. 2020 06; 51(12):1447-1449. PMID: 32445529.
      Citations:    Fields:    Translation:HumansCells
    129. Tan MC, Mansour N, White DL, Sisson A, El-Serag HB, Thrift AP. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients. Aliment Pharmacol Ther. 2020 07; 52(1):20-36. PMID: 32452599; PMCID: PMC7293564.
      Citations: 13     Fields:    Translation:Humans
    130. Kaul V, Shah VH, El-Serag H. Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic. Gastroenterology. 2020 09; 159(3):809-812. PMID: 32425233; PMCID: PMC7233251.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    131. Tseng CH, Tseng CM, Wu JL, Hsu YC, El-Serag HB. Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. J Gastroenterol Hepatol. 2020 Oct; 35(10):1684-1693. PMID: 32343431.
      Citations: 7     Fields:    Translation:Humans
    132. Miftahussurur M, Waskito LA, El-Serag HB, Ajami NJ, Nusi IA, Syam AF, Matsumoto T, Rezkitha YAA, Doohan D, Fauzia KA, Maimunah U, Sugihartono T, Uchida T, Yamaoka Y. Gastric microbiota and Helicobacter pylori in Indonesian population. Helicobacter. 2020 Aug; 25(4):e12695. PMID: 32395907.
      Citations: 7     Fields:    Translation:HumansCells
    133. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, AGA Institute. Electronic address: ewilson@gastro.org. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul; 159(1):320-334.e27. PMID: 32407808; PMCID: PMC7212965.
      Citations: 157     Fields:    Translation:HumansCellsPHPublic Health
    134. Balakrishnan M, Patel P, Dunn-Valadez S, Dao C, Khan V, Ali H, El-Serag L, Hernaez R, Sisson A, Thrift AP, Liu Y, El-Serag HB, Kanwal F. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15. PMID: 32360810; PMCID: PMC8796200.
      Citations: 41     Fields:    Translation:Humans
    135. El-Serag HB, Sardell R, Thrift AP, Kanwal F, Miller P. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. Dig Dis Sci. 2021 03; 66(3):912-916. PMID: 32303951.
      Citations: 5     Fields:    Translation:Humans
    136. Puenpatom A, Cao Y, Yu X, Kanwal F, El-Serag HB, Kramer JR. Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection. Infect Dis Ther. 2020 Jun; 9(2):355-365. PMID: 32297307; PMCID: PMC7237563.
      Citations: 1     
    137. Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB, AGA Institute. Electronic address: ewilson@gastro.org. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology. 2020 Aug; 159(2):739-758.e4. PMID: 32247018; PMCID: PMC7118600.
      Citations: 115     Fields:    Translation:HumansCellsPHPublic Health
    138. El-Serag HB, Kanwal F, Feng Z, Marrero JA, Khaderi S, Singal AG, Texas Hepatocellular Carcinoma Consortium. Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology. 2020 07; 159(1):376-377. PMID: 32234536; PMCID: PMC8375364.
      Citations: 8     Fields:    Translation:Humans
    139. Nguyen TH, Tan MC, Liu Y, Rugge M, Thrift AP, El-Serag HB. Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol. 2021 02; 19(2):269-276.e3. PMID: 32184184; PMCID: PMC7890574.
      Citations: 5     Fields:    Translation:HumansCells
    140. Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol. 2021 05; 19(5):876-884. PMID: 32147593; PMCID: PMC8559554.
      Citations: 31     Fields:    Translation:Humans
    141. Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387. PMID: 31899705.
      Citations: 13     Fields:    Translation:Humans
    142. Kanwal F, Kramer JR, Li L, Dai J, Natarajan Y, Yu X, Asch SM, El-Serag HB. Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology. 2020 03; 71(3):808-819. PMID: 31675427.
      Citations: 38     Fields:    Translation:Humans
    143. Loomba R, Lim JK, Patton H, El-Serag HB. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 2020 05; 158(6):1822-1830. PMID: 32006545; PMCID: PMC8012107.
      Citations: 61     Fields:    Translation:HumansPHPublic Health
    144. Choi DT, Puenpatom A, Yu X, Erickson KF, Kanwal F, El-Serag HB, Kramer JR. Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698. PMID: 31862503; PMCID: PMC8724917.
      Citations: 2     Fields:    Translation:HumansCells
    145. Ayyagari S, Tan MC, Liu Y, El-Serag HB, Thrift AP. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699. PMID: 31802383.
      Citations: 2     Fields:    Translation:Humans
    146. Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson L, Karasic T, Llovet J, Finn R, Groopman J, El-Serag H, Monga S, Wang XW, Karin M, Schwartz R, Tanabe K, Roberts L, Gunaratne P, Tsung A, Brown K, Lawrence T, Salem R, Singal A, Kim A, Rabiee A, Resar L, Meyer J, Hoshida Y, He AR, Ghoshal K, Ryan P, Jaffee E, Guha C, Mishra L, Coleman N, Ahmed M. Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. Cancer Res. 2019 Nov 15; 79(22):5897. PMID: 31772073.
      Citations: 3     Fields:    
    147. Nguyen TH, Mallepally N, Hammad T, Liu Y, Thrift AP, El-Serag HB, Tan MC. Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci. 2020 08; 65(8):2403-2411. PMID: 31728790; PMCID: PMC7220821.
      Citations: 9     Fields:    Translation:HumansCells
    148. Zhang X, El-Serag HB, Thrift AP. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):88-94. PMID: 31712271.
      Citations: 10     Fields:    Translation:Humans
    149. Shapiro J, El-Serag HB, Chan J. Durability and Effectiveness of Cognitive-Behavioral Therapy for Irritable Bowel Syndrome. Gastroenterology. 2019 12; 157(6):1684-1686. PMID: 31614122.
      Citations:    Fields:    
    150. Hashim D, Boffetta P, El-Serag HB, Bertuccio P, Malvezzi M, Carioli G, La Vecchia C, Negri E. Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma". J Hepatol. 2019 12; 71(6):1262-1263. PMID: 31564445.
      Citations: 5     Fields:    Translation:Humans
    151. Liu Y, Ajami NJ, El-Serag HB, Hair C, Graham DY, White DL, Chen L, Wang Z, Plew S, Kramer J, Cole R, Hernaez R, Hou J, Husain N, Jarbrink-Sehgal ME, Kanwal F, Ketwaroo G, Natarajan Y, Shah R, Velez M, Mallepally N, Petrosino JF, Jiao L. Dietary quality and the colonic mucosa-associated gut microbiome in humans. Am J Clin Nutr. 2019 09 01; 110(3):701-712. PMID: 31291462; PMCID: PMC6736447.
      Citations: 32     Fields:    Translation:HumansCells
    152. Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM. Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. Cancer Res. 2019 09 01; 79(17):4326-4330. PMID: 31481419; PMCID: PMC8330805.
      Citations: 45     Fields:    Translation:Humans
    153. Kanwal F, Kramer JR, Asch SM, Cao Y, Li L, El-Serag HB. Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. Hepatology. 2020 01; 71(1):44-55. PMID: 31222774.
      Citations: 60     Fields:    Translation:Humans
    154. Shobassy M, Husainat N, Tabash A, Patel K, El-Serag HB, Othman MO. Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1. Gastroenterol Res Pract. 2019; 2019:5290642. PMID: 31485218; PMCID: PMC6710758.
      Citations: 1     
    155. Graham DY, Dang BN, El-Serag HB. Helicobacter pylori Infection. N Engl J Med. 2019 08 08; 381(6):587-588. PMID: 31390511.
      Citations:    Fields:    Translation:HumansCells
    156. Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 03; 18(3):534-542. PMID: 31362118; PMCID: PMC8859863.
      Citations: 201     Fields:    Translation:Humans
    157. Cano JJ, Thrift AP, El-Serag HB. Prospective implementation of algorithmic patient selection for gastrostomy tube placement consultations: a pre- and post-intervention analysis. Clin Exp Gastroenterol. 2019; 12:231-237. PMID: 31213872; PMCID: PMC6549408.
      Citations:    
    158. Shapiro JM, El-Serag HB, Gandle C, Peacock C, Denson LA, Fishman LN, Hernaez R, Hou JK. Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clin Gastroenterol Hepatol. 2020 02; 18(2):276-289.e2. PMID: 31077824.
      Citations: 2     Fields:    Translation:Humans
    159. Zou WY, Choi K, Kramer JR, Yu X, Cao Y, El-Serag HB, Kanwal F. Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents. Dig Dis Sci. 2019 11; 64(11):3328-3336. PMID: 31041639; PMCID: PMC6819241.
      Citations: 5     Fields:    Translation:Humans
    160. Kim HS, El-Serag HB. The Epidemiology of Hepatocellular Carcinoma in the USA. Curr Gastroenterol Rep. 2019 Apr 11; 21(4):17. PMID: 30976932.
      Citations: 46     Fields:    Translation:Humans
    161. Gantuya B, El-Serag HB, Matsumoto T, Ajami NJ, Oyuntsetseg K, Azzaya D, Uchida T, Yamaoka Y. Gastric Microbiota in Helicobacter pylori-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area. Cancers (Basel). 2019 Apr 10; 11(4). PMID: 30974798; PMCID: PMC6520852.
      Citations: 27     
    162. El-Serag HB, Christie IC, Puenpatom A, Castillo D, Kanwal F, Kramer JR. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection. Aliment Pharmacol Ther. 2019 06; 49(11):1442-1447. PMID: 30932218; PMCID: PMC6510621.
      Citations: 13     Fields:    Translation:HumansCells
    163. Hashim D, Boffetta P, El-Serag HB, Bertuccio P, Malvezzi M, Carioli G, La Vecchia C, Negri E. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019 07; 71(1):104-114. PMID: 30910538.
      Citations: 99     Fields:    Translation:Humans
    164. Kim HS, Yang JD, El-Serag HB, Kanwal F. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019 05; 26(5):596-602. PMID: 30629790.
      Citations: 18     Fields:    Translation:Humans
    165. Gurwara S, Ajami NJ, Jang A, Hessel FC, Chen L, Plew S, Wang Z, Graham DY, Hair C, White DL, Kramer J, Kourkoumpetis T, Hoffman K, Cole R, Hou J, Husain N, Jarbrink-Sehgal M, Hernaez R, Kanwal F, Ketwaroo G, Shah R, Velez M, Natarajan Y, El-Serag HB, Petrosino JF, Jiao L. Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon. Nutrients. 2019 Mar 13; 11(3). PMID: 30871224; PMCID: PMC6470629.
      Citations: 17     Fields:    Translation:HumansCells
    166. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB. Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. Am J Gastroenterol. 2019 03; 114(3):530-532. PMID: 30699099; PMCID: PMC9768962.
      Citations: 11     Fields:    Translation:Humans
    167. Jiao L, Maity S, Coarfa C, Rajapakshe K, Chen L, Jin F, Putluri V, Tinker LF, Mo Q, Chen F, Sen S, Sangi-Hyghpeykar H, El-Serag HB, Putluri N. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246. PMID: 30723176; PMCID: PMC6445762.
      Citations: 11     Fields:    Translation:Humans
    168. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2019 06; 17(7):1420. PMID: 30710706.
      Citations:    Fields:    Translation:HumansCells
    169. Tansel A, Kramer J, Feng H, El-Serag HB, Kanwal F. Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization. Dig Dis Sci. 2019 06; 64(6):1470-1477. PMID: 30673983.
      Citations:    Fields:    Translation:Humans
    170. Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY. Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285]. J Hepatol. 2019 Mar; 70(3):581. PMID: 30635242.
      Citations:    Fields:    
    171. Thrift AP, Natarajan Y, Liu Y, El-Serag HB. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality. Clin Gastroenterol Hepatol. 2019 09; 17(10):2117-2125.e3. PMID: 30625400; PMCID: PMC6612541.
      Citations: 13     Fields:    Translation:Humans
    172. Hernaez R, Kramer JR, Liu Y, Tansel A, Natarajan Y, Hussain KB, Gerbes A, El-Serag HB, Kanwal F, Gin?s P, Sol? E, Moreau R. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647. PMID: 30590100.
      Citations: 28     Fields:    Translation:Humans
    173. Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. Clin Gastroenterol Hepatol. 2019 08; 17(9):1886-1893.e5. PMID: 30557738; PMCID: PMC6570589.
      Citations: 16     Fields:    Translation:Humans
    174. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2004. PMID: 30454938; PMCID: PMC6903693.
      Citations:    Fields:    Translation:HumansCells
    175. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2005-2006. PMID: 30454939; PMCID: PMC6903691.
      Citations:    Fields:    Translation:HumansCells
    176. Husain NS, El-Serag HB. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Nat Rev Clin Oncol. 2018 12; 15(12):728-730. PMID: 30237519.
      Citations: 1     Fields:    Translation:Humans
    177. Sparkman J, Hernaez R, El-Serag HB. Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma. Transl Gastroenterol Hepatol. 2018; 3:97. PMID: 30603733; PMCID: PMC6286889.
      Citations: 2     
    178. Hammad TA, Thrift AP, El-Serag HB, Husain NS. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2019 02; 64(2):367-372. PMID: 30370493; PMCID: PMC6358496.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    179. Tau A, Bernica J, Thrift AP, El-Serag HB. Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures. Gastroenterology. 2019 02; 156(3):809-811. PMID: 30514636.
      Citations:    Fields:    Translation:Humans
    180. Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019 01; 156(2):477-491.e1. PMID: 30367835; PMCID: PMC6340716.
      Citations: 420     Fields:    Translation:Humans
    181. Thrift AP, Liu Y, Tsavachidis S, White DL, El-Serag HB. Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection. Clin Gastroenterol Hepatol. 2019 08; 17(9):1912-1914. PMID: 30342914; PMCID: PMC7050728.
      Citations:    Fields:    Translation:Humans
    182. Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM, Chu J, El-Serag HB. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2. PMID: 30144434; PMCID: PMC6279617.
      Citations: 165     Fields:    Translation:Humans
    183. Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci. 2018 11; 63(11):3112-3119. PMID: 30109579; PMCID: PMC6185782.
      Citations: 13     Fields:    Translation:Humans
    184. Nguyen P, Valanejad L, Cast A, Wright M, Garcia JM, El-Serag HB, Karns R, Timchenko NA. Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPa-p300 Axis. Cell Rep. 2018 08 07; 24(6):1597-1609. PMID: 30089269; PMCID: PMC8209958.
      Citations: 20     Fields:    Translation:HumansAnimals
    185. Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, Virani SS, Garcia JM, El-Serag HB, Jiao L. Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study. J Clin Med. 2018 Aug 02; 7(8). PMID: 30072610; PMCID: PMC6111748.
      Citations: 4     
    186. El-Serag HB. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018 09; 155(3):607-609. PMID: 30076836; PMCID: PMC6366444.
      Citations: 1     Fields:    Translation:Humans
    187. Dong J, Gu X, El-Serag HB, Thrift AP. Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. Clin Gastroenterol Hepatol. 2019 03; 17(4):657-665.e13. PMID: 30036643.
      Citations: 12     Fields:    Translation:Humans
    188. Kramer JR, Puenpatom A, Erickson KF, Cao Y, Smith D, El-Serag HB, Kanwal F. Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system. J Viral Hepat. 2018 11; 25(11):1270-1279. PMID: 29851265; PMCID: PMC6202183.
      Citations: 9     Fields:    Translation:HumansCells
    189. Sealock RJ, Thrift AP, El-Serag HB, Sellin J. Long-term follow up of patients with obscure gastrointestinal bleeding examined with video capsule endoscopy. Medicine (Baltimore). 2018 Jul; 97(29):e11429. PMID: 30024515; PMCID: PMC6086509.
      Citations: 4     Fields:    Translation:Humans
    190. Tan MC, El-Serag HB, Yu X, Thrift AP. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. Aliment Pharmacol Ther. 2018 08; 48(4):469-477. PMID: 29956826.
      Citations:    
    191. Nguyen T, Khan A, Liu Y, El-Serag HB, Thrift AP. The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans. Am J Gastroenterol. 2018 09; 113(9):1310. PMID: 29946180.
      Citations: 11     Fields:    Translation:Humans
    192. Tan MC, Kanthasamy KA, Yeh AG, Kil D, Pompeii L, Yu X, El-Serag HB, Thrift AP. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation. Clin Gastroenterol Hepatol. 2019 01; 17(1):65-72.e5. PMID: 29902646.
      Citations: 2     Fields:    Translation:Humans
    193. Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155. PMID: 29880962.
      Citations: 13     Fields:    Translation:HumansCells
    194. Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol. 2018 Jun 01; 47(3):966-975. PMID: 29672681; PMCID: PMC6005108.
      Citations: 22     Fields:    
    195. Kanwal F, Mapaskhi S, Smith D, Taddei T, Hussain K, Madu S, Duong N, White D, Cao Y, Mehta R, El-Serag H, Asch S, Midboe A. Implementation of a Population-Based Cirrhosis Identification and Management System. Clin Gastroenterol Hepatol. 2018 08; 16(8):1182-1186.e2. PMID: 29803805; PMCID: PMC7185902.
      Citations: 5     Fields:    Translation:Humans
    196. Thakur ER, Shapiro J, Chan J, Lumley MA, Cully JA, Bradford A, El-Serag HB. A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study. Dig Dis Sci. 2018 09; 63(9):2189-2201. PMID: 29744772.
      Citations: 4     Fields:    Translation:Humans
    197. Hernaez R, Kanwal F, El-Serag HB. Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9. PMID: 29315712.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    198. Hernaez R, El-Serag HB. How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794. PMID: 29713029.
      Citations: 6     Fields:    Translation:Humans
    199. Shah R, Ho EY, Kramer JR, Richardson P, Sansgiry S, El-Serag HB, Hou JK. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists. Dig Dis Sci. 2018 06; 63(6):1551-1557. PMID: 29663266.
      Citations: 4     Fields:    Translation:HumansCells
    200. Hsu YC, Ho HJ, Lee TY, Huang YT, Wu MS, Lin JT, Wu CY, El-Serag HB. Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. J Viral Hepat. 2018 05; 25(5):543-551. PMID: 29193536.
      Citations: 9     Fields:    Translation:Humans
    201. White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, Tinker L, Rohan T, Whitsel EA, El-Serag HB, Jiao L. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018 05; 7(5):2180-2191. PMID: 29573228; PMCID: PMC5943487.
      Citations: 4     Fields:    Translation:Humans
    202. El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018 07; 16(7):992-1002.e6. PMID: 29559361; PMCID: PMC6913173.
      Citations: 54     Fields:    Translation:HumansCells
    203. Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. J Hepatol. 2018 08; 69(2):278-285. PMID: 29551708.
      Citations: 35     Fields:    Translation:Humans
    204. Zou WY, El-Serag HB, Sada YH, Temple SL, Sansgiry S, Kanwal F, Davila JA. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181. PMID: 29508165; PMCID: PMC6010049.
      Citations: 3     Fields:    Translation:Humans
    205. Mapakshi S, Kramer JR, Richardson P, El-Serag HB, Kanwal F. Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications. Clin Gastroenterol Hepatol. 2018 10; 16(10):1677-1678. PMID: 29410051.
      Citations: 20     Fields:    Translation:Humans
    206. Balakrishnan M, El-Serag HB, Balakrishnan M, El-Serag HB. Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis? Aliment Pharmacol Ther. 2018 02; 47(3):437-438. PMID: 29314126; PMCID: PMC5765763.
      Citations:    
    207. Vanga RR, Tansel A, Sidiq S, El-Serag HB, Othman MO. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 08; 16(8):1220-1228.e4. PMID: 29374614; PMCID: PMC6402774.
      Citations: 31     Fields:    Translation:Humans
    208. Alter H, Block T, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Chisari FV, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten T, Guo H, Guo JT, Hoshida Y, Hu J, Kowdley KV, Li W, Liang J, Locarnini S, Lok AS, Mason W, McMahon B, Mehta A, Perrillo R, Revill P, Rice CM, Rinaudo J, Schinazi R, Seeger C, Shetty K, Tavis J, Zoulim F. A research agenda for curing chronic hepatitis B virus infection. Hepatology. 2018 03; 67(3):1127-1131. PMID: 28877549; PMCID: PMC5873273.
      Citations: 38     Fields:    Translation:HumansCells
    209. Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol. 2018 01 04; 18(1):1. PMID: 29301497; PMCID: PMC5753461.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    210. Bhakta D, Graham DY, Chan J, El-Serag HB. Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2018 09; 16(9):1531-1532. PMID: 29306045; PMCID: PMC6913178.
      Citations: 3     Fields:    Translation:HumansCells
    211. Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB. Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2018 01 01; 110(1). PMID: 28922784; PMCID: PMC6059156.
      Citations: 18     Fields:    Translation:HumansAnimals
    212. Block TM, Alter H, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten TF, Guo JT, Hoshida Y, Kowdley KV, Li W, Lok AS, McMahon B, Mehta A, Perrillo R, Rice CM, Rinaudo J, Schinazi RF, Shetty K. Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop. Antiviral Res. 2018 02; 150:93-100. PMID: 29248746; PMCID: PMC6309822.
      Citations: 10     Fields:    Translation:HumansCells
    213. Kaur M, Singapura P, Kalakota N, Cruz G, Shukla R, Ahsan S, Tansel A, Thrift AP, El-Serag HB. Factors That Contribute to Indeterminate Results From the?QuantiFERON-TB Gold In-Tube Test in Patients With?Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 10; 16(10):1616-1621.e1. PMID: 29175527.
      Citations: 3     Fields:    Translation:HumansCells
    214. El-Serag HB, Margaret M, Alkek AB. Current Status of Sorafenib Use for Treatment of Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2017 Oct; 13(10):623-625. PMID: 29230141; PMCID: PMC5718181.
      Citations: 1     
    215. Lin M, Kramer J, White D, Cao Y, Tavakoli-Tabasi S, Madu S, Smith D, Asch SM, El-Serag HB, Kanwal F. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents. Aliment Pharmacol Ther. 2017 11; 46(10):992-1000. PMID: 28949020; PMCID: PMC5800315.
      Citations: 33     Fields:    Translation:HumansCells
    216. Royse KE, El-Serag HB, Chen L, White DL, Hale L, Sangi-Haghpeykar H, Jiao L. Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study. J Womens Health (Larchmt). 2017 12; 26(12):1270-1277. PMID: 28933583; PMCID: PMC6037184.
      Citations: 1     Fields:    Translation:Humans
    217. Maret-Ouda J, Wahlin K, El-Serag HB, Lagergren J. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA. 2017 09 12; 318(10):939-946. PMID: 28898377; PMCID: PMC5818853.
      Citations: 12     Fields:    Translation:Humans
    218. Camilleri M, Wilcox CM, El-Serag HB, Kanwal F. Anniversary Tribute From the Editors of Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2017 12; 15(12):1823-1827. PMID: 28911951.
      Citations:    Fields:    Translation:Humans
    219. Mittal S, Kramer JR, Omino R, Chayanupatkul M, Richardson PA, El-Serag HB, Kanwal F. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018 02; 16(2):252-259. PMID: 28870660.
      Citations: 12     Fields:    Translation:Humans
    220. Redman JS, Natarajan Y, Hou JK, Wang J, Hanif M, Feng H, Kramer JR, Desiderio R, Xu H, El-Serag HB, Kanwal F. Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Dig Dis Sci. 2017 10; 62(10):2713-2718. PMID: 28861720.
      Citations: 10     Fields:    Translation:Humans
    221. Kramer JR, El-Serag HB, Taylor TJ, White DL, Asch SM, Frayne SM, Cao Y, Smith DL, Kanwal F. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study. J Viral Hepat. 2017 11; 24(11):955-965. PMID: 28815822; PMCID: PMC5638671.
      Citations: 1     Fields:    Translation:HumansCells
    222. El-Serag HB, Zhu AX, Johnson MS. The treatment path in hepatocellular carcinoma. Clin Adv Hematol Oncol. 2017 Aug; 15 Suppl 9(8):1-20. PMID: 29036035.
      Citations: 3     Fields:    Translation:Humans
    223. El-Serag HB. Advances in the management of hepatocellular carcinoma. Clin Adv Hematol Oncol. 2017 Aug; 15 Suppl 9(8):2-6. PMID: 29036036.
      Citations: 1     Fields:    Translation:Humans
    224. Massarweh NN, El-Serag HB. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control. 2017 Jul-Sep; 24(3):1073274817729245. PMID: 28975830; PMCID: PMC5937247.
      Citations: 152     Fields:    Translation:Humans
    225. Naik AD, El-Serag HB. Endoscopic ablation of low-grade dysplasia in Barrett's?esophagus: Have all the boxes been checked for?us?to move on? Gastrointest Endosc. 2017 07; 86(1):130-132. PMID: 28610854.
      Citations:    Fields:    Translation:Humans
    226. Balakrishnan M, El-Serag HB, Nguyen T, Hilal J, Kanwal F, Thrift AP. Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures. Clin Gastroenterol Hepatol. 2017 12; 15(12):1965-1967. PMID: 28642206; PMCID: PMC5693622.
      Citations: 5     Fields:    Translation:Humans
    227. Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017 10; 153(4):996-1005.e1. PMID: 28642197.
      Citations: 263     Fields:    Translation:Humans
    228. Kanwal F, Tansel A, Kramer JR, Feng H, Asch SM, El-Serag HB. Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. Am J Gastroenterol. 2017 Aug; 112(8):1287-1297. PMID: 28607480.
      Citations: 20     Fields:    Translation:Humans
    229. El-Serag HB. A Farewell From the Board of Editors of the Blue Journal. Clin Gastroenterol Hepatol. 2017 06; 15(6):797-798. PMID: 28528938.
      Citations:    Fields:    
    230. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017 Dec; 15(12):1833-1843. PMID: 28532700.
      Citations: 72     Fields:    Translation:Humans
    231. Royse KE, Chen L, Berger DH, Ittmann MM, El-Serag HB, Balentine CJ, Graham DY, Richardson PA, Rumbaut RE, Shen X, White DL, Jiao L. Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma. Int J Mol Epidemiol Genet. 2017; 8(2):8-18. PMID: 28533893; PMCID: PMC5435667.
      Citations: 4     
    232. Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GN?3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909. PMID: 28291238.
      Citations: 3     Fields:    Translation:Humans
    233. Thrift AP, Vaughan TL, Anderson LA, Whiteman DC, El-Serag HB. External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126. PMID: 28300685; PMCID: PMC5474137.
      Citations: 12     Fields:    Translation:Humans
    234. Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg. 2017 Mar; 6(2):75-87. PMID: 28446996; PMCID: PMC5387154.
      Citations: 3     
    235. Nguyen T, Thrift AP, Yu X, Duan Z, El-Serag HB. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1049-1055. PMID: 28244499.
      Citations: 4     Fields:    Translation:Humans
    236. Holmberg D, Ness-Jensen E, Mattsson F, El-Serag HB, Lagergren J. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus. Eur J Cancer. 2017 04; 75:41-46. PMID: 28214656.
      Citations: 4     Fields:    Translation:Humans
    237. Tansel A, Katz LH, El-Serag HB, Thrift AP, Parepally M, Shakhatreh MH, Kanwal F. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1207-1217.e4. PMID: 28215616; PMCID: PMC5522646.
      Citations: 28     Fields:    Translation:Humans
    238. Kramer JR, Richardson P, Sansgiry S, El-Serag HB, Hou JK. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260. PMID: 27997433.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    239. Hernaez R, El-Serag HB. Hepatocellular carcinoma surveillance: The road ahead. Hepatology. 2017 03; 65(3):771-773. PMID: 27943335.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    240. Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3. PMID: 28110098.
      Citations: 20     Fields:    Translation:Humans
    241. Brusselaers N, Maret-Ouda J, Konings P, El-Serag HB, Lagergren J. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017 04 01; 140(7):1693-1699. PMID: 28006838.
      Citations: 29     Fields:    Translation:Humans
    242. Hernaez R, El-Serag H. ?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. Ann Hepatol. 2017 Jan-Feb 2017; 16(1):16-20. PMID: 28051790.
      Citations:    Fields:    Translation:Humans
    243. Tan MC, Murrey-Ittmann J, Nguyen T, Ketwaroo GA, El-Serag HB, Thrift AP. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250. PMID: 28036381; PMCID: PMC5201279.
      Citations: 1     Fields:    Translation:Humans
    244. Tan MC, El-Serag HB, Hou JK. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Dig Dis Sci. 2017 03; 62(3):607-614. PMID: 28012103.
      Citations: 4     Fields:    Translation:Humans
    245. Balakrishnan M, El-Serag HB, Kanwal F, Thrift AP. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. Dig Dis Sci. 2017 02; 62(2):526-533. PMID: 27995401.
      Citations: 9     Fields:    Translation:Humans
    246. Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):122-132. PMID: 27924080.
      Citations: 121     Fields:    Translation:Humans
    247. Kanwal F, El-Serag HB. The Top Five Reasons You Should Publish in Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2017 02; 15(2):164-165. PMID: 27913243.
      Citations:    Fields:    Translation:Humans
    248. Davidson NO, El-Serag HB. How to Prepare for and Write a Grant: Personal Perspectives. Gastroenterology. 2017 01; 152(1):7-11. PMID: 27889573.
      Citations: 1     Fields:    Translation:Humans
    249. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology. 2017 03; 152(4):812-820.e5. PMID: 27889576; PMCID: PMC5346030.
      Citations: 155     Fields:    Translation:Humans
    250. Balakrishnan M, Kanwal F, El-Serag HB, Thrift AP. Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2017 02; 15(2):310-312. PMID: 27712983; PMCID: PMC5241175.
      Citations: 7     Fields:    Translation:Humans
    251. Chayanupatkul M, Omino R, Mittal S, Kramer JR, Richardson P, Thrift AP, El-Serag HB, Kanwal F. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017 02; 66(2):355-362. PMID: 27693539.
      Citations: 41     Fields:    Translation:HumansCells
    252. Shukla R, Kramer J, Cao Y, Ying J, Tansel A, Walder A, Advani S, El-Serag HB, Kanwal F. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol. 2016 12; 111(12):1778-1787. PMID: 27670600.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    253. Natarajan Y, White DL, El-Serag HB, Ramsey D, Richardson P, Kuzniarek J, Shukla R, Tansel A, Kanwal F. Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV. Dig Dis Sci. 2017 01; 62(1):76-83. PMID: 27655101.
      Citations: 2     Fields:    Translation:Humans
    254. Maret-Ouda J, El-Serag HB, Lagergren J. Opportunities for Preventing Esophageal Adenocarcinoma. Cancer Prev Res (Phila). 2016 Nov; 9(11):828-834. PMID: 27623934.
      Citations: 9     Fields:    Translation:Humans
    255. Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535. PMID: 27575711; PMCID: PMC5209791.
      Citations: 14     Fields:    Translation:Humans
    256. Thrift AP, Kanwal F, El-Serag HB. Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated. Clin Gastroenterol Hepatol. 2016 12; 14(12):1678-1680. PMID: 27574756.
      Citations: 10     Fields:    Translation:Humans
    257. Bhakta D, Hair C, Green L, Duong N, Thrift AP, Kramer JR, El-Serag HB. Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy. Clin Gastroenterol Hepatol. 2017 01; 15(1):137-139. PMID: 27567695.
      Citations:    Fields:    Translation:Humans
    258. Khalaf N, Ying J, Mittal S, Temple S, Kanwal F, Davila J, El-Serag HB. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2017 02; 15(2):273-281.e1. PMID: 27521507.
      Citations: 46     Fields:    Translation:Humans
    259. Mittal S, Kanwal F, Ying J, Chung R, Sada YH, Temple S, Davila JA, El-Serag HB. Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. J Hepatol. 2016 12; 65(6):1148-1154. PMID: 27476765; PMCID: PMC5322857.
      Citations: 50     Fields:    Translation:Humans
    260. Thakur ER, Quigley BM, El-Serag HB, Gudleski GD, Lackner JM. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. J Psychosom Res. 2016 09; 88:48-53. PMID: 27521653; PMCID: PMC5006683.
      Citations: 5     Fields:    Translation:Humans
    261. Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP. Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3. PMID: 27264393; PMCID: PMC5028323.
      Citations: 6     Fields:    Translation:Humans
    262. Shiota S, El-Serag HB, Thrift AP. Weight Change and Weight Cycling Are?Not?Associated With Risk of Barrett's?Esophagus. Clin Gastroenterol Hepatol. 2016 12; 14(12):1839-1840. PMID: 27264394.
      Citations:    Fields:    Translation:Humans
    263. Kanwal F, Kramer JR, El-Serag HB, Frayne S, Clark J, Cao Y, Taylor T, Smith D, White D, Asch SM. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. Clin Infect Dis. 2016 08 01; 63(3):291-9. PMID: 27131869; PMCID: PMC6276931.
      Citations: 35     Fields:    Translation:HumansCells
    264. Kanwal F, Asch SM, Kramer JR, Cao Y, Asrani S, El-Serag HB. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016 08; 64(2):569-81. PMID: 26991920.
      Citations: 30     Fields:    Translation:Humans
    265. El-Serag HB, Kanwal F, Richardson P, Kramer J. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016 07; 64(1):130-7. PMID: 26946190; PMCID: PMC4917456.
      Citations: 143     Fields:    Translation:Humans
    266. Chen L, Duan Z, Tinker L, Sangi-Haghpeykar H, Strickler H, Ho GY, Gunter MJ, Rohan T, Logsdon C, White DL, Royse K, El-Serag HB, Jiao L. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. Cancer Epidemiol. 2016 06; 42:115-23. PMID: 27100837; PMCID: PMC4899266.
      Citations: 8     Fields:    Translation:Humans
    267. El-Serag HB, Kramer J, Duan Z, Kanwal F. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat. 2016 09; 23(9):687-96. PMID: 27040447.
      Citations: 13     Fields:    Translation:Humans
    268. Bhise V, Modi V, Kalavar A, Espadas D, Hanser L, Gould M, El-Serag HB, Singh H. Patient-Reported Attributions for Missed Colonoscopy Appointments in Two Large Healthcare Systems. Dig Dis Sci. 2016 07; 61(7):1853-61. PMID: 26971093.
      Citations: 10     Fields:    Translation:Humans
    269. Hou J, Richardson P, El-Serag H, Davila J, Sada Y. Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Med Care. 2016 Feb; 54(2):e9-14. PMID: 23929403; PMCID: PMC3875602.
      Citations: 20     Fields:    Translation:Humans
    270. Walker M, El-Serag HB, Sada Y, Mittal S, Ying J, Duan Z, Richardson P, Davila JA, Kanwal F. Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther. 2016 Mar; 43(5):621-30. PMID: 26784271; PMCID: PMC4742403.
      Citations: 27     Fields:    Translation:Humans
    271. Lin M, Pappas SC, Sellin J, El-Serag HB. Curbside Consultations: The Good, the Bad, and the Ugly. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):2-4. PMID: 26698231.
      Citations: 1     Fields:    Translation:Humans
    272. Blais P, Lin M, Kramer JR, El-Serag HB, Kanwal F. Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia. Dig Dis Sci. 2016 06; 61(6):1714-20. PMID: 26707137.
      Citations: 23     Fields:    Translation:Humans
    273. Chan JL, El-Serag HB. Is Proton Pump Inhibitor Use Associated With Risk of Myocardial Infarction? Gastroenterology. 2016 Feb; 150(2):526-7. PMID: 26718176.
      Citations: 2     Fields:    Translation:Humans
    274. Sajja KC, El-Serag HB, Thrift AP. Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus. Clin Gastroenterol Hepatol. 2016 May; 14(5):769-72. PMID: 26681488; PMCID: PMC4837040.
      Citations: 6     Fields:    Translation:Humans
    275. Shiota S, El-Serag HB, Thrift AP. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47. PMID: 26611860; PMCID: PMC4791183.
      Citations:    Fields:    Translation:Humans
    276. Thrift AP, El-Serag HB. Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations. Clin Gastroenterol Hepatol. 2016 Mar; 14(3):330-2. PMID: 26528803.
      Citations: 9     Fields:    Translation:Humans
    277. White DL, Richardson P, Tayoub N, Davila JA, Kanwal F, El-Serag HB. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. Gastroenterology. 2015 Dec; 149(7):1986-7. PMID: 26519622; PMCID: PMC5082743.
      Citations: 21     Fields:    Translation:Humans
    278. Massarweh NN, Davila JA, El-Serag HB, Duan Z, Temple S, May S, Sada YH, Anaya DA. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9. PMID: 26507276.
      Citations: 8     Fields:    Translation:Humans
    279. Maret-Ouda J, Tao W, Mattsson F, Brusselaers N, El-Serag HB, Lagergren J. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017 Jan; 13(1):28-34. PMID: 26723560.
      Citations: 10     Fields:    Translation:Humans
    280. Patel KK, Cummings S, Sellin J, Scott L, El-Serag HB. Applying Lean Design Principles to a Gastrointestinal Endoscopy Program for Uninsured Patients Improves Health Care Utilization. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1556-9.e4. PMID: 26296924.
      Citations: 1     Fields:    Translation:Humans
    281. Fallon MB, Kanwal F, El-Serag HB. The Art and Science of Managing Liver Disease. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2029-30. PMID: 26325399.
      Citations:    Fields:    Translation:Humans
    282. El-Serag HB, Naik AD, Duan Z, Shakhatreh M, Helm A, Pathak A, Hinojosa-Lindsey M, Hou J, Nguyen T, Chen J, Kramer JR. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus. Gut. 2016 08; 65(8):1252-60. PMID: 26311716.
      Citations: 47     Fields:    Translation:Humans
    283. Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R, Goldblum J, Gress F, Ilson DH, Inadomi JM, Kuipers EJ, Lynch JP, McKeon F, Metz D, Pasricha PJ, Peek R, Peters JH, Repici A, Seewald S, Shaheen NJ, Souza RF, Spechler SJ, Vennalaganti P, Wang K, Pech O. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015 Nov; 149(6):1599-606. PMID: 26296479; PMCID: PMC4820399.
      Citations: 24     Fields:    Translation:Humans
    284. Kanwal F, Kramer JR, Duan Z, Yu X, White D, El-Serag HB. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):301-8.e1-2. PMID: 26291667; PMCID: PMC4918764.
      Citations: 67     Fields:    Translation:Humans
    285. Singal AG, El-Serag HB. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2140-51. PMID: 26284591; PMCID: PMC4618036.
      Citations: 215     Fields:    Translation:Humans
    286. Shiota S, Singh S, Anshasi A, El-Serag HB. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1907-18. PMID: 26260107; PMCID: PMC4615528.
      Citations: 30     Fields:    Translation:Humans
    287. Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver?Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):191-202.e1-4; quiz e20. PMID: 26256464; PMCID: PMC4805368.
      Citations: 39     Fields:    Translation:Humans
    288. Nguyen T, Duan Z, Naik AD, Kramer JR, El-Serag HB. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. Gastroenterology. 2015 Nov; 149(6):1392-8. PMID: 26208896.
      Citations: 15     Fields:    Translation:Humans
    289. Mittal S, El-Serag HB, Sada YH, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1. PMID: 26196445; PMCID: PMC4690789.
      Citations: 209     Fields:    Translation:Humans
    290. Hou JK, Turkeltaub JA, McCarty Iii TR, El-Serag HB. Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease. World J Gastroenterol. 2015 May 21; 21(19):6001-7. PMID: 26019466; PMCID: PMC4438036.
      Citations: 3     Fields:    Translation:Humans
    291. El-Serag H, Lagergren J, Ness-Jensen E, Hveem K. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):175-82.e1-3. PMID: 25956834; PMCID: PMC4636482.
      Citations: 50     Fields:    Translation:Humans
    292. Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149(2):340-9.e2. PMID: 25921377; PMCID: PMC4516571.
      Citations: 72     Fields:    Translation:Humans
    293. Rustgi A, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2015 04 09; 372(15):1472-3. PMID: 25853757.
      Citations: 31     Fields:    Translation:Humans
    294. Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29. PMID: 25836985; PMCID: PMC4778392.
      Citations: 38     Fields:    Translation:Humans
    295. Thrift AP, Hilal J, El-Serag HB. Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther. 2015 Jun; 41(11):1182-9. PMID: 25801197; PMCID: PMC4511846.
      Citations:    
    296. Khalaf N, White D, Kanwal F, Ramsey D, Mittal S, Tavakoli-Tabasi S, Kuzniarek J, El-Serag HB. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin Gastroenterol Hepatol. 2015 Aug; 13(8):1521-31.e3. PMID: 25777972.
      Citations: 15     Fields:    Translation:Humans
    297. Hilal J, El-Serag HB, Ramsey D, Ngyuen T, Kramer JR. Physical activity and the risk of Barrett's esophagus. Dis Esophagus. 2016 Apr; 29(3):248-54. PMID: 25715656.
      Citations:    
    298. Dubnansky EC, Lowe CB, Petrovic TK, Brounstein LM, El-Serag HB, Turner JR, Bishr Omary M. Why send your paper to Gastroenterology: global outreach and partnerships with sister journals, CGH and CMGH, among a menu of offerings. Gastroenterology. 2015 Apr; 148(4):673-8. PMID: 25705033.
      Citations:    Fields:    Translation:Humans
    299. Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M, Cole R, Anand B, Vela M, El-Serag HB. The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15. PMID: 25689684.
      Citations: 16     Fields:    Translation:HumansCells
    300. Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1616-24. PMID: 25681693; PMCID: PMC6905083.
      Citations: 52     Fields:    Translation:HumansCells
    301. Kanwal F, White DL, Jiao L, Tavakoli-Tabasi S, Sansgiry S, Ramsey DJ, Kuzniarek J, Spiegelman A, El-Serag HB. Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection. Dig Dis Sci. 2015 Jul; 60(7):2030-7. PMID: 25663241.
      Citations: 2     Fields:    Translation:Humans
    302. Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ. Reply: To PMID 24957400. Dig Dis Sci. 2015 Feb; 60(2):587. PMID: 25756151.
      Citations:    Fields:    Translation:HumansPHPublic Health
    303. Berzosa M, Villa N, El-Serag HB, Sejpal DV, Patel KK. Comparison of endoscopic ultrasound guided 22-gauge core needle with standard 25-gauge fine-needle aspiration for diagnosing solid pancreatic lesions. Endosc Ultrasound. 2015 Jan-Mar; 4(1):28-33. PMID: 25789281; PMCID: PMC4362000.
      Citations: 17     
    304. Boeckxstaens G, El-Serag HB, Kahrilas PJ, Smout AJ. Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J. 2015 Jan; 91(1071):46-54. PMID: 25583739; PMCID: PMC4316838.
      Citations: 5     Fields:    
    305. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014 Dec 25; 371(26):2499-509. PMID: 25539106.
      Citations: 483     Fields:    Translation:Humans
    306. Kanwal F, El-Serag HB, Ross D. Surveillance for hepatocellular carcinoma: can we focus on the mission? Clin Gastroenterol Hepatol. 2015 Apr; 13(4):805-7. PMID: 25541193.
      Citations: 9     Fields:    Translation:Humans
    307. Nguyen TH, Thrift AP, Ramsey D, Green L, Shaib YH, Graham DY, El-Serag HB. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80. PMID: 25420546.
      Citations: 15     Fields:    Translation:HumansCells
    308. Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2014 Dec; 60(6):1871-8. PMID: 25065513; PMCID: PMC4245372.
      Citations: 24     Fields:    Translation:Humans
    309. White DL, Liu Y, Garcia J, El-Serag HB, Jiao L, Tsavachidis S, Franco LM, Lee JS, Tavakoli-Tabasi S, Moore D, Goldman R, Kuzniarek J, Ramsey DJ, Kanwal F, Marcelli M. Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males. Int J Mol Epidemiol Genet. 2014; 5(3):164-76. PMID: 25379136; PMCID: PMC4214264.
      Citations: 7     
    310. Shakhatreh MH, Duan Z, Kramer J, Naik AD, Helm A, Hinojosa-Lindsey M, Chen GJ, El-Serag HB. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett's esophagus. Am J Gastroenterol. 2014 Dec; 109(12):1862-8; quiz 1861, 1869. PMID: 25331350.
      Citations: 11     Fields:    Translation:Humans
    311. Tyson GL, Ilyas JA, Duan Z, Green LK, Younes M, El-Serag HB, Davila JA. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci. 2014 Dec; 59(12):3103-10. PMID: 25204668; PMCID: PMC4823008.
      Citations: 37     Fields:    Translation:Humans
    312. Nguyen T, Tang Z, Younes M, Alsarraj A, Ramsey D, Fitzgerald S, Kramer JR, El-Serag HB. Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci. 2015 Jan; 60(1):65-73. PMID: 25185658.
      Citations: 6     Fields:    Translation:Humans
    313. Husain N, Blais P, Kramer J, Kowalkowski M, Richardson P, El-Serag HB, Kanwal F. Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol Ther. 2014 Oct; 40(8):949-54. PMID: 25155259; PMCID: PMC5331854.
      Citations: 16     Fields:    Translation:Humans
    314. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014 Nov; 60(5):1767-75. PMID: 24839253; PMCID: PMC4211957.
      Citations: 252     Fields:    Translation:Humans
    315. Mittal S, Sada YH, El-Serag HB, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):594-601.e1. PMID: 25148760; PMCID: PMC4333060.
      Citations: 86     Fields:    Translation:Humans
    316. El-Serag HB, Kramer J, Duan Z, Kanwal F. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol. 2014 Sep; 109(9):1427-35. PMID: 25070058.
      Citations: 43     Fields:    Translation:HumansCells
    317. Shakhatreh MH, Duan Z, Avila N, Naik AD, Kramer JR, Hinojosa-Lindsey M, Chen J, El-Serag HB. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):280-6. PMID: 25004461; PMCID: PMC4284151.
      Citations: 4     Fields:    Translation:Humans
    318. Buchanan PM, Kramer JR, El-Serag HB, Asch SM, Assioun Y, Bacon BR, Kanwal F. The quality of care provided to patients with varices in the department of Veterans Affairs. Am J Gastroenterol. 2014 Jul; 109(7):934-40. PMID: 24989087.
      Citations: 21     Fields:    Translation:Humans
    319. Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ. Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci. 2014 Dec; 59(12):2913-26. PMID: 24957400; PMCID: PMC4237622.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    320. El-Serag HB, Kanwal F. Obesity and hepatocellular carcinoma: hype and reality. Hepatology. 2014 Sep; 60(3):779-81. PMID: 24753107.
      Citations: 14     Fields:    Translation:Humans
    321. Hollier JM, Hinojosa-Lindsey M, Sansgiry S, El-Serag HB, Naik AD. Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy. BMC Gastroenterol. 2014 Jun 10; 14:107. PMID: 24916457; PMCID: PMC4079921.
      Citations: 1     Fields:    Translation:Humans
    322. Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015 Jan; 110(1):10-4. PMID: 24890441.
      Citations: 46     Fields:    Translation:Humans
    323. Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag HB. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology. 2014 Jul; 60(1):98-105. PMID: 24615981; PMCID: PMC4689301.
      Citations: 108     Fields:    Translation:HumansCells
    324. Hou JK, Tan M, Stidham RW, Colozzi J, Adams D, El-Serag H, Waljee AK. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014 Oct; 59(10):2406-10. PMID: 24817338; PMCID: PMC6907154.
      Citations: 39     Fields:    Translation:Humans
    325. Naik AD, El-Serag HB. Decision aids for shared decision-making in Barrett's esophagus surveillance. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):91-3. PMID: 24823291; PMCID: PMC6999123.
      Citations: 4     Fields:    Translation:Humans
    326. Nguyen T, Khalaf N, Ramsey D, El-Serag HB. Statin use is associated with a decreased risk of Barrett's esophagus. Gastroenterology. 2014 Aug; 147(2):314-23. PMID: 24798416.
      Citations: 17     Fields:    Translation:Humans
    327. Khalaf N, Nguyen T, Ramsey D, El-Serag HB. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6. PMID: 24793026; PMCID: PMC4214884.
      Citations: 8     Fields:    Translation:Humans
    328. Nguyen T, Alsarraj A, El-Serag HB. Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing. Dis Esophagus. 2015 Jul; 28(5):418-21. PMID: 24708395.
      Citations:    
    329. Boeckxstaens G, El-Serag HB, Kahrilas PJ, Smout AJ. Symptomatic reflux disease: the present, the past and the future. Gut. 2014 Jul; 63(7):1185-93. PMID: 24607936; PMCID: PMC4078752.
      Citations: 68     Fields:    Translation:Humans
    330. Kanwal F, El-Serag HB. Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1381-3. PMID: 24607698.
      Citations: 7     Fields:    Translation:Humans
    331. Kramer JR, Shakhatreh MH, Naik AD, Duan Z, El-Serag HB. Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. JAMA Intern Med. 2014 Mar; 174(3):462-5. PMID: 24474391; PMCID: PMC4046949.
      Citations: 4     Fields:    Translation:Humans
    332. Pellicano R, El-Serag HB. Hepatology 2014: where are we going? Minerva Gastroenterol Dietol. 2014 Mar; 60(1):1-4. PMID: 24632763.
      Citations:    
    333. Kramer JR, Alsarraj A, El-Serag HB, Thrift AP. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23. PMID: 23842216; PMCID: PMC3796119.
      Citations: 9     Fields:    Translation:Humans
    334. Khalaf N, Ramsey D, Kramer JR, El-Serag HB. Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus. 2015 Apr; 28(3):283-90. PMID: 24529029; PMCID: PMC4135032.
      Citations: 2     Fields:    Translation:Humans
    335. Arney J, Hinojosa-Lindsey M, Street RL, Hou J, El-Serag HB, Naik AD. Patient experiences with surveillance endoscopy: a qualitative study. Dig Dis Sci. 2014 Jul; 59(7):1378-85. PMID: 24500449; PMCID: PMC4071114.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    336. Younossi ZM, Kanwal F, Saab S, Brown KA, El-Serag HB, Kim WR, Ahmed A, Kugelmas M, Gordon SC. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31. PMID: 24461160.
      Citations: 34     Fields:    Translation:Humans
    337. El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology. 2014 May; 146(5):1249-55.e1. PMID: 24462733; PMCID: PMC3992177.
      Citations: 81     Fields:    Translation:Humans
    338. Liu Y, El-Serag HB, Jiao L, Lee J, Moore D, Franco LM, Tavakoli-Tabasi S, Tsavachidis S, Kuzniarek J, Ramsey DJ, White DL. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLoS One. 2013; 8(12):e84407. PMID: 24386373; PMCID: PMC3875538.
      Citations: 8     Fields:    Translation:HumansCells
    339. Thrift AP, Garcia JM, El-Serag HB. A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71. PMID: 24362047; PMCID: PMC4063886.
      Citations: 32     Fields:    Translation:Humans
    340. Khandwalla HE, Graham DY, Kramer JR, Ramsey DJ, Duong N, Green LK, El-Serag HB. Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82. PMID: 24343550; PMCID: PMC4046947.
      Citations: 13     Fields:    Translation:Humans
    341. Vela MF, Kramer JR, Richardson PA, Dodge R, El-Serag HB. Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil. 2014 Mar; 26(3):346-52. PMID: 24460751; PMCID: PMC3944589.
      Citations: 10     Fields:    Translation:Humans
    342. Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Response to Braillon. Am J Gastroenterol. 2013 Dec; 108(12):1931. PMID: 24300871.
      Citations:    Fields:    Translation:Humans
    343. Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014 Aug; 63(8):1229-37. PMID: 24221456; PMCID: PMC4199831.
      Citations: 79     Fields:    Translation:Humans
    344. Thrift AP, Kramer JR, Richardson PA, El-Serag HB. No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci. 2014 Jan; 59(1):108-16. PMID: 24114046; PMCID: PMC3976430.
      Citations: 21     Fields:    Translation:Humans
    345. Kanwal F, White DL, Tavakoli-Tabasi S, Jiao L, Lin D, Ramsey DJ, Spiegelman A, Kuzniarek J, El-Serag HB. Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):327-333.e1. PMID: 23978349; PMCID: PMC3971998.
      Citations: 3     Fields:    Translation:Humans
    346. Mittal S, Lin YL, Tan A, Kuo YF, El-Serag HB, Goodwin JS. Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014 Mar; 12(3):443-450.e1. PMID: 23973925; PMCID: PMC3944371.
      Citations: 7     Fields:    Translation:Humans
    347. Jiao L, Kramer JR, Chen L, Rugge M, Parente P, Verstovsek G, Alsarraj A, El-Serag HB. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther. 2013 Oct; 38(7):817-24. PMID: 23957669; PMCID: PMC3811083.
      Citations: 14     Fields:    Translation:Humans
    348. Hartman CM, El-Serag HB, Giordano TP, Chiao EY. The impact of HIV viral control on the incidence of HIV-associated anal cancer. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):631-8. PMID: 23614995; PMCID: PMC3797186.
      Citations: 16     Fields:    Translation:Humans
    349. Garcia JM, Splenser AE, Kramer J, Alsarraj A, Fitzgerald S, Ramsey D, El-Serag HB. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):229-238.e3. PMID: 23954649; PMCID: PMC3899092.
      Citations: 37     Fields:    Translation:Humans
    350. Kanwal F, Hoang T, Chrusciel T, Kramer JR, El-Serag HB, Durfee J, Dominitz JA, Yano EM, Asch SM. Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci. 2014 Feb; 59(2):273-81. PMID: 23934366.
      Citations: 2     Fields:    Translation:Humans
    351. El-Serag HB, Xu F, Biyani P, Cooper GS. Bundling in medicare patients undergoing bidirectional endoscopy: how often does it happen? Clin Gastroenterol Hepatol. 2014 Jan; 12(1):58-63. PMID: 23911874; PMCID: PMC4103975.
      Citations: 4     Fields:    Translation:Humans
    352. Siegel AB, El-Serag HB. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence. Expert Rev Gastroenterol Hepatol. 2013 Aug; 7(6):493-5. PMID: 23984995; PMCID: PMC4083736.
      Citations: 3     Fields:    Translation:Humans
    353. El-Serag HB, Alsarraj A, Richardson P, Davila JA, Kramer JR, Durfee J, Kanwal F. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey. Dig Dis Sci. 2013 Nov; 58(11):3117-26. PMID: 23868438; PMCID: PMC3858077.
      Citations: 9     Fields:    Translation:Humans
    354. Lin D, Kramer JR, Ramsey D, Alsarraj A, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83. PMID: 23857477; PMCID: PMC4046950.
      Citations: 4     Fields:    Translation:Humans
    355. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun; 63(6):871-80. PMID: 23853213; PMCID: PMC4046948.
      Citations: 456     Fields:    Translation:Humans
    356. Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013 Aug; 58(2):538-45. PMID: 23505059; PMCID: PMC3729715.
      Citations: 24     Fields:    Translation:HumansCells
    357. Tyson GL, Richardson PA, White DL, Kuzniarek J, Ramsey DJ, Tavakoli-Tabasi S, El-Serag HB. Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients. J Clin Gastroenterol. 2013 Jul; 47(6):545-52. PMID: 23426443; PMCID: PMC3664139.
      Citations: 1     Fields:    Translation:Humans
    358. Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013 Jul; 47 Suppl:S2-6. PMID: 23632345; PMCID: PMC3683119.
      Citations: 480     Fields:    Translation:Humans
    359. Kanwal F, El-Serag H. Improving quality of care in patients with cirrhosis. Clin Liver Dis (Hoboken). 2013 Jun; 2(3):123-124. PMID: 30992842; PMCID: PMC6448634.
      Citations:    
    360. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47. PMID: 23776098; PMCID: PMC3808509.
      Citations: 25     Fields:    Translation:Humans
    361. Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013 Aug; 108(8):1314-21. PMID: 23752878; PMCID: PMC4105976.
      Citations: 122     Fields:    Translation:Humans
    362. White DL, Tavakoli-Tabasi S, Kanwal F, Ramsey DJ, Hashmi A, Kuzniarek J, Patel P, Francis J, El-Serag HB. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther. 2013 Jul; 38(1):28-37. PMID: 23710689; PMCID: PMC3742078.
      Citations: 7     Fields:    Translation:Humans
    363. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1399-1412.e7. PMID: 23707461; PMCID: PMC3873801.
      Citations: 110     Fields:    Translation:Humans
    364. Naik AD, Hinojosa-Lindsey M, Arney J, El-Serag HB, Hou J. Choosing Wisely and the perceived drivers of endoscopy use. Clin Gastroenterol Hepatol. 2013 Jul; 11(7):753-5. PMID: 23664894; PMCID: PMC3845025.
      Citations: 8     Fields:    Translation:Humans
    365. Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22. PMID: 23567358; PMCID: PMC3972036.
      Citations: 37     Fields:    Translation:HumansCells
    366. Hou JK, Kramer JR, Richardson P, Mei M, El-Serag HB. The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64. PMID: 23448789; PMCID: PMC3972034.
      Citations: 19     Fields:    Translation:Humans
    367. Davila JA, Kramer JR, Duan Z, Richardson PA, Tyson GL, Sada YH, Kanwal F, El-Serag HB. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013 May; 57(5):1858-68. PMID: 23359313; PMCID: PMC4046942.
      Citations: 26     Fields:    Translation:Humans
    368. Kanwal F, Lok AS, El-Serag HB. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Gastroenterology. 2013 Mar; 144(3):478-81. PMID: 23419454.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    369. Kanwal F, Lok AS, El-Serag HB. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):200-3. PMID: 23432900.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    370. Sealock RJ, Kramer JR, Verstovsek G, Richardson P, Rugge M, Parente P, Vela M, El-Serag HB. The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther. 2013 Apr; 37(8):825-32. PMID: 23441936; PMCID: PMC3602156.
      Citations: 9     Fields:    Translation:Humans
    371. Jiao L, Kramer JR, Rugge M, Parente P, Verstovsek G, Alsarraj A, El-Serag HB. Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control. 2013 May; 24(5):1005-14. PMID: 23420329; PMCID: PMC3633655.
      Citations: 14     Fields:    Translation:HumansAnimals
    372. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, Anand B, Graham DY, Kramer JR. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9. PMID: 23408348; PMCID: PMC3976427.
      Citations: 49     Fields:    Translation:Humans
    373. Qureshi Z, Ramsey D, Kramer JR, Whitehead L, El-Serag HB. Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci. 2013 Jul; 58(7):1967-75. PMID: 23381104; PMCID: PMC3976431.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    374. Hinojosa-Lindsey M, Arney J, Heberlig S, Kramer JR, Street RL, El-Serag HB, Naik AD. Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. Dis Esophagus. 2013 Sep-Oct; 26(7):682-9. PMID: 23383987; PMCID: PMC3981464.
      Citations: 9     Fields:    Translation:Humans
    375. Villa N, El-Serag HB, Younes M, Ertan A. Esophageal eosinophilia after radiofrequency ablation for Barrett's esophagus. Dis Esophagus. 2013 Sep-Oct; 26(7):674-7. PMID: 23384233.
      Citations:    
    376. El-Serag HB, Kanwal F. a-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):441-3. PMID: 23376321.
      Citations: 13     Fields:    Translation:Humans
    377. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013 Jan 15; 108(1):213-21. PMID: 23287986; PMCID: PMC3553538.
      Citations: 41     Fields:    Translation:Humans
    378. Kramer JR, Fischbach LA, Richardson P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Velez M, Cole R, Anand B, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1. PMID: 23220167; PMCID: PMC3606681.
      Citations: 45     Fields:    Translation:Humans
    379. Jiao L, Chen L, Alsarraj A, Ramsey D, Duan Z, El-Serag HB. Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma. Int J Mol Epidemiol Genet. 2012; 3(4):294-304. PMID: 23205181; PMCID: PMC3508542.
      Citations: 6     
    380. Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S, Alsarraj A, Shaib Y, Velez ME, Abraham N, Anand B, Cole R, El-Serag HB. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71. PMID: 23147524; PMCID: PMC3984401.
      Citations: 24     Fields:    Translation:HumansCells
    381. Hou JK, Chang M, Nguyen T, Kramer JR, Richardson P, Sansgiry S, D'Avolio LW, El-Serag HB. Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing. Dig Dis Sci. 2013 Apr; 58(4):936-41. PMID: 23086115; PMCID: PMC3974588.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    382. Jafri NS, Gould M, El-Serag HB, Duan Z, Davila JA. Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci. 2013 Jul; 58(7):2052-60. PMID: 23086126.
      Citations: 15     Fields:    Translation:Humans
    383. Hou JK, Kramer JR, Richardson P, Sansgiry S, El-Serag HB. Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56. PMID: 23061548; PMCID: PMC3998909.
      Citations: 3     Fields:    Translation:Humans
    384. El-Serag HB. Surveillance for hepatocellular carcinoma: long way to achieve effectiveness. Dig Dis Sci. 2012 Dec; 57(12):3050-1. PMID: 23053890.
      Citations: 7     Fields:    Translation:Humans
    385. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012 Dec; 10(12):1342-1359.e2. PMID: 23041539; PMCID: PMC3501546.
      Citations: 270     Fields:    Translation:Humans
    386. Singh H, Khan R, Giardina TD, Paul LW, Daci K, Gould M, El-Serag H. Postreferral colonoscopy delays in diagnosis of colorectal cancer: a mixed-methods analysis. Qual Manag Health Care. 2012 Oct-Dec; 21(4):252-61. PMID: 23011072; PMCID: PMC3702372.
      Citations: 12     Fields:    Translation:Humans
    387. White DL, Tavakoli-Tabasi S, Kuzniarek J, Ramsey DJ, El-Serag HB. Racial differences in the association between adiposity measures and the risk of hepatitis C-related liver disease. J Clin Gastroenterol. 2012 Oct; 46(9):779-88. PMID: 22955261; PMCID: PMC3437036.
      Citations: 1     Fields:    Translation:HumansCells
    388. El-Serag HB, Duan Z, Hinojosa-Lindsey M, Hou J, Shakhatreh M, Naik AD, Chen GJ, Street RL, Kramer JR. Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012 Oct; 76(4):743-55. PMID: 22985642; PMCID: PMC4689298.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    389. Kramer JR, Arney J, Chen J, Richardson P, Duan Z, Street RL, Hinojosa-Lindsey M, Naik AD, El-Serag HB. Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288. PMID: 22929214; PMCID: PMC3508612.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    390. El-Serag HB, Hollier JM, Gravitt P, Alsarraj A, Younes M. Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus. 2013 Jul; 26(5):517-21. PMID: 22891654; PMCID: PMC4412355.
      Citations: 6     Fields:    Translation:HumansCells
    391. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012 Aug; 46(7):581-9. PMID: 22772738; PMCID: PMC3972042.
      Citations: 49     Fields:    Translation:Humans
    392. Kanwal F, Hoang T, Chrusciel T, Kramer JR, El-Serag HB, Dominitz JA, Asch SM. Process of care for hepatitis C infection is linked to treatment outcome and virologic response. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1270-1277.e3. PMID: 22841970; PMCID: PMC5810922.
      Citations: 11     Fields:    Translation:Humans
    393. Kanwal F, Hoang T, Kramer J, Chrusciel T, El-Serag H, Dominitz JA, Asch SM. The performance of process measures in hepatitis C. Am J Gastroenterol. 2012 Oct; 107(10):1512-21. PMID: 22777337.
      Citations: 13     Fields:    Translation:Humans
    394. El-Serag HB. The new board of editors for clinical gastroenterology and hepatology: our vision and plans. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):690-1. PMID: 22721437.
      Citations:    Fields:    Translation:Humans
    395. White DL, Hashmi A, Ramsey DJ, Kuzniarek J, Tavakoli-Tabasi S, El-Serag HB. Finasteride and methadone use and risk of advanced hepatitis C related liver disease. Dig Dis Sci. 2012 Nov; 57(11):3004-10. PMID: 22669204.
      Citations: 1     Fields:    Translation:Humans
    396. Lacy BE, Talley NJ, Locke GR, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. PMID: 22591037; PMCID: PMC3970847.
      Citations:    
    397. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012 May; 142(6):1264-1273.e1. PMID: 22537432; PMCID: PMC3338949.
      Citations: 1267     Fields:    Translation:HumansCells
    398. Kanwal F, Kramer JR, Buchanan P, Asch SM, Assioun Y, Bacon BR, Li J, El-Serag HB. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012 Jul; 143(1):70-7. PMID: 22465432.
      Citations: 57     Fields:    Translation:Humans
    399. Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter. 2012 Jun; 17(3):163-75. PMID: 22515353; PMCID: PMC3335759.
      Citations: 27     Fields:    Translation:HumansCells
    400. Nordenstedt H, Younes M, El-Serag HB. Expression of androgen receptors in Barrett esophagus. J Clin Gastroenterol. 2012 Mar; 46(3):251-2. PMID: 22327304; PMCID: PMC4057097.
      Citations: 3     Fields:    Translation:Humans
    401. Talley NJ, Locke GR, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. PMID: 22343090; PMCID: PMC4289143.
      Citations: 17     Fields:    Translation:Humans
    402. Nordenstedt H, Mattsson F, El-Serag H, Lagergren J. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer. 2012 Feb 28; 106(5):1011-5. PMID: 22240785; PMCID: PMC3305961.
      Citations:    
    403. Ward JW, Lok AS, Thomas DL, El-Serag HB, Kim WR. Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology. 2012 Jan; 55(1):307-15. PMID: 22105599.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    404. Davila JA, Duan Z, McGlynn KA, El-Serag HB. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 2012 Jan; 46(1):71-7. PMID: 22157221; PMCID: PMC3832893.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    405. El-Serag HB. Writing and publishing scientific papers. Gastroenterology. 2012 Feb; 142(2):197-200. PMID: 22178211.
      Citations: 4     Fields:    
    406. White DL, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey DJ, El-Serag HB. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012 Mar; 55(3):759-68. PMID: 21858849; PMCID: PMC3399504.
      Citations: 35     Fields:    Translation:Humans
    407. Richardson P, Duan Z, Kramer J, Davila JA, Tyson GL, El-Serag HB. Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):428-33. PMID: 22155556; PMCID: PMC3311729.
      Citations: 23     Fields:    Translation:Humans
    408. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22; 365(12):1118-27. PMID: 21992124.
      Citations: 1793     Fields:    Translation:Humans
    409. Quigley EM, Jacobson BC, Lenglinger J, Rubenstein JH, El-Serag H, Cicala M, McCallum RW, Levine MS, Gore RM. Barrett's esophagus: clinical features, obesity, and imaging. Ann N Y Acad Sci. 2011 Sep; 1232:36-52. PMID: 21950806.
      Citations: 3     Fields:    Translation:Humans
    410. Hou JK, Kramer JR, Richardson P, Mei M, El-Serag HB. Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis. 2012 Jun; 18(6):1011-7. PMID: 22334479; PMCID: PMC3976425.
      Citations: 9     Fields:    Translation:Humans
    411. Tyson GL, Duan Z, Kramer JR, Davila JA, Richardson PA, El-Serag HB. Level of a-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Nov; 9(11):989-94. PMID: 21820396; PMCID: PMC3200479.
      Citations: 14     Fields:    Translation:Humans
    412. Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011 Sep; 34(6):618-27. PMID: 21770991.
      Citations:    
    413. Kramer JR, Kanwal F, Richardson P, Mei M, El-Serag HB. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012 Feb; 56(2):320-5. PMID: 21756855.
      Citations: 30     Fields:    Translation:Humans
    414. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011 Jul; 54(1):173-84. PMID: 21488076; PMCID: PMC3125451.
      Citations: 309     Fields:    Translation:Humans
    415. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011 Aug; 54(2):463-71. PMID: 21538440; PMCID: PMC4141525.
      Citations: 203     Fields:    Translation:Humans
    416. Lagergren J, Mattsson F, El-Serag H, Nordenstedt H. Increased risk of hepatocellular carcinoma after cholecystectomy. Br J Cancer. 2011 Jun 28; 105(1):154-6. PMID: 21610710; PMCID: PMC3137401.
      Citations:    
    417. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr; 106(4):563-73. PMID: 21468064.
      Citations: 299     Fields:    Translation:HumansAnimals
    418. Hou J, El-Serag H, Sellin J, Thirumurthi S. Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians. Dig Dis Sci. 2011 May; 56(5):1476-81. PMID: 21394463.
      Citations: 5     Fields:    Translation:Humans
    419. Nguyen DM, El-Serag HB, Shub M, Integlia M, Henderson L, Richardson P, Fairly K, Gilger MA. Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. Gastrointest Endosc. 2011 May; 73(5):875-80. PMID: 21354565; PMCID: PMC3083476.
      Citations: 2     Fields:    Translation:Humans
    420. Hassall E, Owen D, Kerr W, Sturby T, Richardson P, El-Serag H. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther. 2011 Apr; 33(7):829-36. PMID: 21320136.
      Citations:    
    421. Stepanova M, Kanwal F, El-Serag HB, Younossi ZM. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011 Mar; 53(3):737-45. PMID: 21319199.
      Citations: 34     Fields:    Translation:Humans
    422. Nordenstedt H, El-Serag H. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011 May; 46(5):597-602. PMID: 21271900.
      Citations: 17     Fields:    Translation:Humans
    423. El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut. 2011 Jul; 60(7):992-7. PMID: 21257990.
      Citations: 40     Fields:    Translation:Humans
    424. Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, El-Serag HB. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011 Jan 18; 154(2):85-93. PMID: 21242365.
      Citations: 134     Fields:    Translation:HumansCellsPHPublic Health
    425. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol. 2011 Jan; 4(1):5-10. PMID: 21317990; PMCID: PMC3036965.
      Citations: 52     
    426. White DL, Richardson PA, Al-Saadi M, Fitzgerald SJ, Green L, Amaratunge C, Anand M, El-Serag HB. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011 Jun; 56(6):1835-47. PMID: 21188525; PMCID: PMC3383839.
      Citations: 1     Fields:    Translation:Humans
    427. Marrero JA, El-Serag HB. Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology. 2011 Mar; 53(3):1060-1; author reply 1061-2. PMID: 21374678.
      Citations: 32     Fields:    Translation:HumansPHPublic Health
    428. Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, Richardson P, El-Serag HB. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011 Apr; 140(4):1182-1188.e1. PMID: 21184757; PMCID: PMC3073667.
      Citations: 160     Fields:    Translation:Humans
    429. El-Serag HB, Graham DY. Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. Gastroenterology. 2011 Feb; 140(2):386-8. PMID: 21172329.
      Citations: 8     Fields:    Translation:Humans
    430. Kramer JR, Hachem CY, Kanwal F, Mei M, El-Serag HB. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011 Jan; 53(1):42-52. PMID: 21254161.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    431. Pellicano R, El-Serag HB, Rizzetto M. Hepatocellular carcinoma at the cutting edge of science and practice. Minerva Med. 2010 Dec; 101(6):391-3. PMID: 21196898.
      Citations:    
    432. Kramer JR, Kanwal F, Richardson P, Giordano TP, Petersen LA, El-Serag HB. Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol. 2011 Mar; 106(3):483-91. PMID: 21063393.
      Citations: 39     Fields:    Translation:HumansCells
    433. Richardson P, Henderson L, Davila JA, Kramer JR, Fitton CP, Chen GJ, El-Serag HB. Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci. 2010 Nov; 55(11):3241-51. PMID: 20844957.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    434. El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010 Sep; 32(6):720-37. PMID: 20662774.
      Citations:    
    435. Sealock RJ, Rendon G, El-Serag HB. Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther. 2010 Sep; 32(6):712-9. PMID: 20662785.
      Citations: 17     Fields:    Translation:Humans
    436. Jacobson IM, Davis GL, El-Serag H, Negro F, Tr?po C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2010 Nov; 8(11):924-33; quiz e117. PMID: 20713178.
      Citations: 44     Fields:    Translation:Humans
    437. El-Serag HB, Talwalkar J, Kim WR. Efficacy, effectiveness, and comparative effectiveness in liver disease. Hepatology. 2010 Aug; 52(2):403-7. PMID: 20683939.
      Citations: 13     Fields:    Translation:Humans
    438. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010 Jul; 42 Suppl 3:S206-14. PMID: 20547305; PMCID: PMC3392755.
      Citations: 217     Fields:    Translation:HumansPHPublic Health
    439. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010 Jul; 52(1):132-41. PMID: 20578139; PMCID: PMC3835698.
      Citations: 154     Fields:    Translation:HumansPHPublic Health
    440. Singh H, Petersen LA, Daci K, Collins C, Khan M, El-Serag HB. Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? Qual Saf Health Care. 2010 Oct; 19(5):e27. PMID: 20584706; PMCID: PMC2965264.
      Citations: 22     Fields:    Translation:Humans
    441. White DL, Savas LS, Daci K, Elserag R, Graham DP, Fitzgerald SJ, Smith SL, Tan G, El-Serag HB. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther. 2010 Aug; 32(4):551-61. PMID: 20528828; PMCID: PMC2906642.
      Citations: 21     Fields:    Translation:Humans
    442. Nguyen DM, Schwartz J, Richardson P, El-Serag HB. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci. 2010 Dec; 55(12):3404-7. PMID: 20397052.
      Citations: 15     Fields:    Translation:Humans
    443. Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):709-17. PMID: 20385251.
      Citations: 53     Fields:    Translation:Humans
    444. Lok AS, Kim WR, El-Serag HB, Maddrey WC. Overview of the viral hepatitis problem. J Fam Pract. 2010 Apr; 59(4 Suppl):S11-6. PMID: 20398585.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    445. El-Serag H, McGlynn KA, Graham GN, So S, Howell CD, Fang T, Anderson JT, Thiel TK. Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. J Fam Pract. 2010 Apr; 59(4 Suppl):S37-42. PMID: 20398589; PMCID: PMC4550292.
      Citations: 7     Fields:    Translation:Humans
    446. Thakkar K, Boatright RO, Gilger MA, El-Serag HB. Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010 Apr; 125(4):e925-30. PMID: 20351005.
      Citations: 31     Fields:    Translation:Humans
    447. Fisher DA, Zullig LL, Grambow SC, Abbott DH, Sandler RS, Fletcher RH, El-Serag HB, Provenzale D. Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci. 2010 May; 55(5):1434-41. PMID: 20238248; PMCID: PMC2864330.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    448. Singh H, Schiesser R, Anand G, Richardson PA, El-Serag HB. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):523-9. PMID: 20303416; PMCID: PMC2879470.
      Citations: 27     Fields:    Translation:Humans
    449. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am. 2010 Mar; 39(1):1-7. PMID: 20202574; PMCID: PMC2833287.
      Citations: 162     Fields:    Translation:Humans
    450. Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun; 138(7):2260-6. PMID: 20188100; PMCID: PMC2883678.
      Citations: 67     Fields:    Translation:Humans
    451. El-Serag H, Lok AS, Thomas DL. The dawn of a new era: transforming our domestic response to hepatitis B & C. Gastroenterology. 2010 Apr; 138(4):1225-30, 1230.e1-3. PMID: 20176024.
      Citations: 2     Fields:    Translation:Humans
    452. Henderson LM, Patel S, Giordano TP, Green L, El-Serag HB. Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci. 2010 Jan; 55(1):190-5. PMID: 19731022; PMCID: PMC3698853.
      Citations: 10     Fields:    Translation:Humans
    453. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010 Feb; 138(2):513-21, 521.e1-6. PMID: 19861128.
      Citations: 314     Fields:    Translation:HumansCells
    454. Graham DP, Savas L, White D, El-Serag R, Laday-Smith S, Tan G, El-Serag HB. Irritable bowel syndrome symptoms and health related quality of life in female veterans. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):261-73. PMID: 19814746; PMCID: PMC2887289.
      Citations: 9     Fields:    Translation:Humans
    455. El-Serag HB, Naik AD. Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology. 2009 Sep; 137(3):763-5. PMID: 19643189; PMCID: PMC2855541.
      Citations: 3     Fields:    Translation:Humans
    456. Thakkar K, Chen L, Tatevian N, Shulman RJ, McDuffie A, Tsou M, Gilger MA, El-Serag HB. Diagnostic yield of oesophagogastroduodenoscopy in children with abdominal pain. Aliment Pharmacol Ther. 2009 Sep 15; 30(6):662-9. PMID: 19573168; PMCID: PMC3018747.
      Citations: 16     Fields:    Translation:Humans
    457. El-Serag HB, Fitzgerald S, Richardson P. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep; 104(9):2161-7. PMID: 19568229.
      Citations: 11     Fields:    Translation:Humans
    458. Nguyen DM, El-Serag HB. The big burden of obesity. Gastrointest Endosc. 2009 Oct; 70(4):752-7. PMID: 19559415.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    459. Singh H, Daci K, Petersen LA, Collins C, Petersen NJ, Shethia A, El-Serag HB. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 Oct; 104(10):2543-54. PMID: 19550418; PMCID: PMC2758321.
      Citations: 62     Fields:    Translation:Humans
    460. Nguyen DM, El-Serag HB, Henderson L, Stein D, Bhattacharyya A, Sampliner RE. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1299-304. PMID: 19523538; PMCID: PMC2789910.
      Citations: 52     Fields:    Translation:Humans
    461. Hussain K, El-Serag HB. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2009 Jun; 55(2):123-38. PMID: 19305372.
      Citations:    
    462. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009 Aug; 104(8):2100-9. PMID: 19471256.
      Citations: 70     Fields:    Translation:Humans
    463. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009 May 01; 29(9):938-46. PMID: 19220208.
      Citations:    
    464. Khandwalla HE, Fasakin Y, El-Serag HB. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol. 2009 Jun; 104(6):1401-5. PMID: 19491852.
      Citations: 4     Fields:    Translation:Humans
    465. Hachem C, Morgan R, Johnson M, Kuebeler M, El-Serag H. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8. PMID: 19352344; PMCID: PMC4144072.
      Citations: 20     Fields:    Translation:Humans
    466. Singh H, Kadiyala H, Bhagwath G, Shethia A, El-Serag H, Walder A, Velez ME, Petersen LA. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol. 2009 Apr; 104(4):942-52. PMID: 19293786; PMCID: PMC2921791.
      Citations: 39     Fields:    Translation:HumansPHPublic Health
    467. El-Serag HB, Lagergren J. Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2009 Apr; 136(4):1155-7. PMID: 19236968; PMCID: PMC2823126.
      Citations: 4     Fields:    Translation:Humans
    468. Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009; 22(7):571-87. PMID: 19222528; PMCID: PMC4018839.
      Citations: 14     Fields:    Translation:Humans
    469. El-Serag HB, Johnson ML, Hachem C, Morgana RO. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009 May; 136(5):1601-8. PMID: 19208359; PMCID: PMC2677134.
      Citations: 94     Fields:    Translation:Humans
    470. El-Serag HB, Nurgalieva ZZ, Mistretta TA, Finegold MJ, Souza R, Hilsenbeck S, Shaw C, Darlington G. Gene expression in Barrett's esophagus: laser capture versus whole tissue. Scand J Gastroenterol. 2009; 44(7):787-95. PMID: 19391063; PMCID: PMC2822542.
      Citations: 23     Fields:    Translation:Humans
    471. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009 Jan; 49(1):116-23. PMID: 19085911; PMCID: PMC2719902.
      Citations: 106     Fields:    Translation:Humans
    472. El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009 Mar 01; 29(5):470-80. PMID: 19035977.
      Citations:    
    473. Kanwal F, El-Serag HB. Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol. 2009 Jan; 50(1):10-2. PMID: 19019482.
      Citations: 1     Fields:    Translation:Humans
    474. El-Serag HB. Epidemiology of non-erosive reflux disease. Digestion. 2008; 78 Suppl 1:6-10. PMID: 18832834.
      Citations: 20     Fields:    Translation:Humans
    475. Savas LS, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, Tan G, Graham DP, Cully JA, El-Serag HB. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009 Jan; 29(1):115-25. PMID: 18785989; PMCID: PMC2939246.
      Citations: 29     Fields:    Translation:Humans
    476. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008 Nov; 49(5):831-44. PMID: 18814931; PMCID: PMC2642971.
      Citations: 140     Fields:    Translation:Humans
    477. Wattacheril J, Kramer JR, Richardson P, Havemann BD, Green LK, Le A, El-Serag HB. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1166-74. PMID: 18691351; PMCID: PMC2596579.
      Citations: 18     Fields:    Translation:Humans
    478. Hachem CY, Kramer JR, Kanwal F, El-Serag HB. Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1078-87. PMID: 18691350.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    479. Gilger MA, El-Serag HB, Gold BD, Dietrich CL, Tsou V, McDuffie A, Shub MD. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr. 2008 Aug; 47(2):141-6. PMID: 18664864.
      Citations: 20     Fields:    Translation:Humans
    480. El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008 Sep; 53(9):2307-12. PMID: 18651221; PMCID: PMC2827866.
      Citations: 78     Fields:    Translation:Humans
    481. Siegel AB, McBride RB, El-Serag HB, Hershman D, Brown RS, Zablotska L, Neugut AI. The risk of hepatocellular carcinoma in patients with previous malignancy. Cancer Invest. 2008 Jun; 26(5):511-5. PMID: 18568774.
      Citations:    Fields:    Translation:Humans
    482. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008 May; 134(6):1752-63. PMID: 18471552.
      Citations: 401     Fields:    Translation:Humans
    483. El-Serag HB, Pilgrim P, Tatevian N, Medrano M, Kitagawa S, Gilger M. Prevalence and histological features of the gastric cardia-type mucosa in children. Dig Dis Sci. 2008 Jul; 53(7):1792-6. PMID: 18373198.
      Citations:    Fields:    Translation:Humans
    484. El-Serag HB, Wieman M, Richardson P. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Jun; 27(12):1293-9. PMID: 18363892.
      Citations:    
    485. Thakkar K, El-Serag HB, Mattek N, Gilger M. Complications of pediatric colonoscopy: a five-year multicenter experience. Clin Gastroenterol Hepatol. 2008 May; 6(5):515-20. PMID: 18356115; PMCID: PMC4999080.
      Citations: 16     Fields:    Translation:Humans
    486. El-Serag H. Role of obesity in GORD-related disorders. Gut. 2008 Mar; 57(3):281-4. PMID: 18268049.
      Citations: 47     Fields:    Translation:Humans
    487. El-Serag HB, White DL, Mitra N. Genetic association studies: from "searching under the lamppost" to "fishing in the pond". Gastroenterology. 2008 Mar; 134(3):662-4. PMID: 18325382.
      Citations: 3     Fields:    Translation:Humans
    488. El-Serag HB. Manuscript writing. Gastrointest Endosc. 2008 Feb; 67(2):311-2. PMID: 18226694.
      Citations:    Fields:    Translation:Humans
    489. Chiao EY, Giordano TP, Richardson P, El-Serag HB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9. PMID: 18202423.
      Citations: 34     Fields:    Translation:Humans
    490. Becher A, El-Serag HB. Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review. Scand J Gastroenterol. 2008; 43(6):645-53. PMID: 18569980.
      Citations: 1     Fields:    Translation:Humans
    491. White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008 Feb 15; 167(4):377-89. PMID: 18065725.
      Citations: 45     Fields:    Translation:Humans
    492. El-Serag H, Kramer JR. Hepatitis C infection: dying with or from the infection? J Hepatol. 2008 Feb; 48(2):183-4. PMID: 18160172.
      Citations:    Fields:    Translation:Humans
    493. Rowan PJ, Dunn NJ, El-Serag HB, Kunik ME. Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. J Viral Hepat. 2007 Dec; 14(12):883-9. PMID: 18070292.
      Citations: 7     Fields:    Translation:Humans
    494. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar; 67(3):394-8. PMID: 18045592.
      Citations: 128     Fields:    Translation:Humans
    495. Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS, Renz JF, Emond J, Neugut AI. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7. PMID: 18005365.
      Citations: 30     Fields:    Translation:Humans
    496. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008 Feb 01; 27(3):274-82. PMID: 17996017.
      Citations: 127     Fields:    Translation:Humans
    497. Kramer JR, Giordano TP, El-Serag HB. Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1321-1328.e7. PMID: 17981246.
      Citations: 7     Fields:    Translation:Humans
    498. Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol. 2007 Nov-Dec; 41(10):911-7. PMID: 18090160.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    499. El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med. 2007 Oct 08; 167(18):1983-9. PMID: 17923599.
      Citations: 63     Fields:    Translation:Humans
    500. El-Serag HB, Graham DY, Rabeneck L, Avid A, Richardson P, Genta RM. Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66. PMID: 17852849.
      Citations: 3     Fields:    Translation:Humans
    501. Davila JA, Weston A, Smalley W, El-Serag HB. Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2007 Sep; 41(8):777-82. PMID: 17700427.
      Citations: 58     Fields:    Translation:HumansPHPublic Health
    502. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007 Sep; 37 Suppl 2:S88-94. PMID: 17877502.
      Citations: 122     
    503. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1221-8. PMID: 17689296; PMCID: PMC2083573.
      Citations: 185     Fields:    Translation:HumansPHPublic Health
    504. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007 Dec; 56(12):1654-64. PMID: 17682001; PMCID: PMC2095717.
      Citations:    
    505. Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 2007 Aug 01; 110(3):660-9. PMID: 17582625.
      Citations: 86     Fields:    Translation:Humans
    506. Le A, Berger D, Lau M, El-Serag HB. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007 Sep; 14(9):2519-27. PMID: 17610016.
      Citations: 19     Fields:    Translation:Humans
    507. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007 Jun; 132(7):2557-76. PMID: 17570226.
      Citations: 2220     Fields:    Translation:Humans
    508. El-Serag HB, Richardson P, Pilgrim P, Gilger MA. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):696-701. PMID: 17544996.
      Citations: 11     Fields:    Translation:Humans
    509. El-Serag HB, Lau M. Temporal trends in new and recurrent oesophageal strictures in a Medicare population. Aliment Pharmacol Ther. 2007 May 15; 25(10):1223-9. PMID: 17451568.
      Citations:    
    510. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007 May 09; 297(18):2010-7. PMID: 17488966.
      Citations: 121     Fields:    Translation:Humans
    511. Abraham NS, El-Serag HB, Hartman C, Richardson P, Deswal A. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther. 2007 Apr 15; 25(8):913-24. PMID: 17402995.
      Citations: 24     Fields:    Translation:Humans
    512. Maheshwari S, Sarraj A, Kramer J, El-Serag HB. Oral contraception and the risk of hepatocellular carcinoma. J Hepatol. 2007 Oct; 47(4):506-13. PMID: 17462781.
      Citations: 29     Fields:    Translation:Humans
    513. Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007 Jul; 102(7):1377-82. PMID: 17403071.
      Citations: 54     Fields:    Translation:HumansPHPublic Health
    514. Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):508-12. PMID: 17382601.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    515. Nurgalieva Z, Lowrey A, El-Serag HB. The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci. 2007 May; 52(5):1345-54. PMID: 17373588.
      Citations: 9     Fields:    Translation:Humans
    516. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007 Mar; 150(3):262-7, 267.e1. PMID: 17307542.
      Citations: 27     Fields:    Translation:Humans
    517. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007 May; 102(5):1016-21. PMID: 17324130.
      Citations: 88     Fields:    Translation:Humans
    518. Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc. 2007 Feb; 65(2):213-21. PMID: 17258979.
      Citations: 36     Fields:    Translation:Humans
    519. Tran T, Lowry AM, El-Serag HB. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):143-53. PMID: 17229239.
      Citations:    
    520. Davila JA, El-Serag HB. GI Epidemiology: databases for epidemiological studies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):169-76. PMID: 17229241.
      Citations:    
    521. El-Serag HB. Translational research: the study of community effectiveness in digestive and liver disorders. Gastroenterology. 2007 Jan; 132(1):8-10. PMID: 17241853.
      Citations: 8     Fields:    Translation:Humans
    522. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):17-26. PMID: 17142109.
      Citations: 126     Fields:    Translation:Humans
    523. El-Serag HB. Scientific manuscripts: the fun of writing and submitting. Gastrointest Endosc. 2006 Dec; 64(6 Suppl):S19-22. PMID: 17113848.
      Citations:    Fields:    Translation:Humans
    524. El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut. 2007 Jun; 56(6):749-55. PMID: 17127706; PMCID: PMC1954847.
      Citations: 96     Fields:    Translation:Humans
    525. El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006 Nov 13; 166(20):2202-8. PMID: 17101937.
      Citations: 48     Fields:    Translation:HumansPHPublic Health
    526. El-Serag HB, Gilger MA, Shub MD, Richardson P, Bancroft J. The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc. 2006 Nov; 64(5):671-5. PMID: 17055854.
      Citations: 8     Fields:    Translation:Humans
    527. El-Serag HB. Gastroesophageal Reflux and the Obesity Epidemic. Gastroenterol Hepatol (N Y). 2006 Nov; 2(11):795-796. PMID: 28381947; PMCID: PMC5368619.
      Citations:    
    528. Lau M, Le A, El-Serag HB. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006 Nov; 101(11):2485-92. PMID: 17029617.
      Citations: 33     Fields:    Translation:Humans
    529. Johnson ML, El-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006 Aug; 44(8):793-7. PMID: 16862043.
      Citations: 16     Fields:    Translation:Humans
    530. El-Serag HB, Tran T, Richardson P, Ergun G. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol. 2006 Aug; 41(8):887-91. PMID: 16803686.
      Citations: 50     Fields:    Translation:Humans
    531. El-Serag HB, Nurgalieva Z, Souza RF, Shaw C, Darlington G. Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc. 2006 Jul; 64(1):17-26. PMID: 16813797.
      Citations: 5     Fields:    Translation:HumansCells
    532. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):87-94. PMID: 16803606.
      Citations:    
    533. El-Serag HB. Temporal trends in new and recurrent esophageal strictures in Department of Veterans Affairs. Am J Gastroenterol. 2006 Aug; 101(8):1727-33. PMID: 16817844.
      Citations: 4     Fields:    Translation:Humans
    534. Giordano TP, Morgan RO, Kramer JR, Hartman C, Richardson P, White CA, Suarez-Almazor ME, El-Serag HB. Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med. 2006 Jun; 21(6):613-7. PMID: 16808745; PMCID: PMC1924608.
      Citations: 11     Fields:    Translation:Humans
    535. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006 Jun; 15(6):1198-203. PMID: 16775181.
      Citations: 68     Fields:    Translation:Humans
    536. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006 Mar; 130(3):639-49. PMID: 16530504.
      Citations: 130     Fields:    Translation:Humans
    537. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):369-80. PMID: 16527702.
      Citations: 282     Fields:    Translation:Humans
    538. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):104-10; quiz 4-5. PMID: 16431312.
      Citations: 50     Fields:    Translation:Humans
    539. Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005 Nov 15; 22(10):1005-10. PMID: 16268976.
      Citations:    
    540. El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006 Jan; 44(1):158-66. PMID: 16290309.
      Citations: 76     Fields:    Translation:HumansPHPublic Health
    541. Julapalli VR, Kramer JR, El-Serag HB, American Association for the Study of Liver Diseases. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005 Nov; 11(11):1370-8. PMID: 16184521.
      Citations: 38     Fields:    Translation:Humans
    542. Abraham NS, El-Serag HB, Johnson ML, Hartman C, Richardson P, Ray WA, Smalley W. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005 Oct; 129(4):1171-8. PMID: 16230071.
      Citations: 40     Fields:    Translation:Humans
    543. El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005 Oct; 100(10):2151-6. PMID: 16181362.
      Citations: 74     Fields:    Translation:Humans
    544. Davila JA, Rabeneck L, Berger DH, El-Serag HB. Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci. 2005 Sep; 50(9):1722-8. PMID: 16133979.
      Citations: 15     Fields:    Translation:Humans
    545. Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, Kunik ME, Satrom SL, El-Serag HB. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol. 2005 Sep; 39(8):731-6. PMID: 16082286.
      Citations: 15     Fields:    Translation:Humans
    546. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 02; 143(3):199-211. PMID: 16061918.
      Citations: 323     Fields:    Translation:Humans
    547. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50. PMID: 15929752.
      Citations: 167     Fields:    Translation:Humans
    548. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May; 54(5):710-7. PMID: 15831922; PMCID: PMC1774487.
      Citations:    
    549. Tran T, Spechler SJ, Richardson P, El-Serag HB. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8. PMID: 15842570.
      Citations: 14     Fields:    Translation:Humans
    550. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005 Apr; 54(4):533-9. PMID: 15753540; PMCID: PMC1774454.
      Citations:    
    551. El-Serag HB. Obesity and disease of the esophagus and colon. Gastroenterol Clin North Am. 2005 Mar; 34(1):63-82. PMID: 15823439.
      Citations: 13     Fields:    Translation:Humans
    552. Kramer JR, Giordano TP, Souchek J, El-Serag HB. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol. 2005 Mar; 42(3):309-14. PMID: 15710213.
      Citations: 16     Fields:    Translation:Humans
    553. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005 Mar; 128(3):620-6. PMID: 15765398.
      Citations: 172     Fields:    Translation:Humans
    554. El-Serag HB, Giordano TP, Kramer J, Richardson P, Souchek J. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):175-83. PMID: 15704052.
      Citations: 7     Fields:    Translation:Humans
    555. El-Serag HB, Mallat DB, Rabeneck L. Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol. 2005 Feb; 39(2):152-9. PMID: 15681913.
      Citations: 10     Fields:    Translation:Humans
    556. Tavakoli-Tabasi S, Rowan P, Abdul-Latif M, Kunik ME, El-Serag HB. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Aliment Pharmacol Ther. 2005 Feb 01; 21(3):235-42. PMID: 15691297.
      Citations: 2     Fields:    Translation:HumansCells
    557. El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005 Jan; 54(1):11-7. PMID: 15591498; PMCID: PMC1774352.
      Citations:    
    558. Abraham NS, Davila JA, Rabeneck L, Berger DH, El-Serag HB. Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther. 2005 Jan 01; 21(1):35-41. PMID: 15644043.
      Citations: 2     Fields:    Translation:Humans
    559. Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T, El-Serag HB. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005 Jan; 146(1):35-40. PMID: 15644819.
      Citations: 154     Fields:    Translation:Humans
    560. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005 Jan; 100(1):162-8. PMID: 15654796.
      Citations: 213     Fields:    Translation:Humans
    561. Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El-Serag HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005 Jan; 100(1):56-63. PMID: 15654781.
      Citations: 58     Fields:    Translation:Humans
    562. Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004 Nov 22; 164(21):2349-54. PMID: 15557414.
      Citations: 47     Fields:    Translation:Humans
    563. Rabeneck L, Davila JA, Thompson M, El-Serag HB. Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system. Aliment Pharmacol Ther. 2004 Nov 15; 20(10):1115-24. PMID: 15569114.
      Citations:    
    564. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S27-34. PMID: 15508094.
      Citations: 310     Fields:    Translation:Humans
    565. Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov; 99(11):2210-6. PMID: 15555004.
      Citations: 60     Fields:    Translation:Humans
    566. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004 Nov; 127(5):1372-80. PMID: 15521006.
      Citations: 159     Fields:    Translation:Humans
    567. Gilger MA, Yeh C, Chiang J, Dietrich C, Brandt ML, El-Serag HB. Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol. 2004 Nov; 2(11):978-84. PMID: 15551250.
      Citations: 12     Fields:    Translation:Humans
    568. El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004 Oct; 99(10):1877-83. PMID: 15447744.
      Citations: 97     Fields:    Translation:Humans
    569. Kulkarni K, Barcak E, El-Serag H, Goodgame R. The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):445-50. PMID: 15298639.
      Citations:    
    570. Rowan PJ, Tabasi S, Abdul-Latif M, Kunik ME, El-Serag HB. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol. 2004 Jul; 38(6):530-4. PMID: 15220690.
      Citations: 27     Fields:    Translation:Humans
    571. El-Serag HB, Aguirre T, Kuebeler M, Sampliner RE. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther. 2004 Jun 15; 19(12):1255-60. PMID: 15191506.
      Citations:    
    572. El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, Rabeneck L. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9. PMID: 15188164.
      Citations: 106     Fields:    Translation:Humans
    573. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004 May; 24(2):115-25. PMID: 15192785.
      Citations: 445     Fields:    Translation:Humans
    574. El-Serag HB, Gilger M, Carter J, Genta RM, Rabeneck L. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol. 2004 May; 99(5):806-12. PMID: 15128341.
      Citations: 23     Fields:    Translation:Humans
    575. El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: Natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004 Apr 15; 19(8):861-70. PMID: 15080847.
      Citations: 24     Fields:    Translation:Humans
    576. Rabeneck L, Davila JA, Thompson M, El-Serag HB. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004 Apr; 99(4):668-75. PMID: 15089900.
      Citations: 19     Fields:    Translation:Humans
    577. El-Serag HB, Garewel H, Kuebeler M, Sampliner RE. Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):296-300. PMID: 15067623.
      Citations: 5     Fields:    Translation:Humans
    578. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54. PMID: 15023166.
      Citations:    
    579. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar; 40(3):472-7. PMID: 15123362.
      Citations: 290     Fields:    Translation:Humans
    580. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004 Mar; 39(3):798-803. PMID: 14999699.
      Citations: 94     Fields:    Translation:Humans
    581. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004 Feb; 126(2):460-8. PMID: 14762783.
      Citations: 400     Fields:    Translation:Humans
    582. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003 Nov 18; 139(10):817-23. PMID: 14623619.
      Citations: 265     Fields:    Translation:Humans
    583. Goodgame B, Shaheen NJ, Galanko J, El-Serag HB. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol. 2003 Nov; 98(11):2535-42. PMID: 14638360.
      Citations: 23     Fields:    Translation:Humans
    584. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003 Aug 15; 18(4):387-93. PMID: 12940923.
      Citations:    
    585. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003 Jul; 98(7):1627-33. PMID: 12873590.
      Citations: 76     Fields:    Translation:Humans
    586. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003 Jun; 98(6):1400-9. PMID: 12818288.
      Citations: 46     Fields:    Translation:HumansPHPublic Health
    587. Graham DY, Hammoud F, El-Zimaity HM, Kim JG, Osato MS, El-Serag HB. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36. PMID: 12755836.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    588. Davila JA, Petersena NJ, Nelson HA, El-Serag HB. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003 May; 56(5):487-93. PMID: 12812824.
      Citations: 15     Fields:    Translation:Humans
    589. Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003 May; 98(5):1186-92. PMID: 12809847.
      Citations: 28     Fields:    Translation:Humans
    590. Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15; 138(8):627-33. PMID: 12693884.
      Citations: 41     Fields:    Translation:Humans
    591. Rabeneck L, El-Serag HB, Davila JA, Sandler RS. Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol. 2003 Feb; 98(2):471-7. PMID: 12591071.
      Citations: 20     Fields:    Translation:Humans
    592. El-Serag HB. Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life. Rev Gastroenterol Disord. 2003; 3 Suppl 2:S3-11. PMID: 12775997.
      Citations: 27     Fields:    Translation:Humans
    593. El-Serag HB, Anand B, Richardson P, Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003 Jan; 98(1):167-74. PMID: 12526953.
      Citations: 30     Fields:    Translation:HumansPHPublic Health
    594. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002 Dec; 36(6):1439-45. PMID: 12447870.
      Citations: 87     Fields:    Translation:Humans
    595. Davila JA, El-Serag HB. Cholangiocarcinoma: the "other" liver cancer on the rise. Am J Gastroenterol. 2002 Dec; 97(12):3199-200. PMID: 12492212.
      Citations: 6     Fields:    Translation:Humans
    596. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002 Nov-Dec; 35(5 Suppl 2):S72-8. PMID: 12394209.
      Citations: 218     Fields:    Translation:Humans
    597. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002 Nov; 36(5 Suppl 1):S74-83. PMID: 12407579.
      Citations: 130     Fields:    Translation:Humans
    598. El-Serag HB, Graham DY, Richardson P, Inadomi JM. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10. PMID: 12374519.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    599. Mallat DB, El-Serag HB. Surveillance for hepatocellular carcinoma: does it work? Am J Gastroenterol. 2002 Oct; 97(10):2676-7. PMID: 12385462.
      Citations:    Fields:    Translation:Humans
    600. Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002 Sep; 35(3):266-9. PMID: 12192205.
      Citations: 46     Fields:    Translation:Humans
    601. El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002 Aug; 37(8):899-904. PMID: 12229963.
      Citations: 31     Fields:    Translation:HumansCells
    602. el-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 Aug; 123(2):476-82. PMID: 12145801.
      Citations: 72     Fields:    Translation:Humans
    603. El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol. 2002 Jul; 97(7):1635-9. PMID: 12135011.
      Citations: 10     Fields:    Translation:Humans
    604. Kim WR, Brown RS, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42. PMID: 12085369.
      Citations: 197     Fields:    Translation:Humans
    605. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002 Jun; 16(6):1171-85. PMID: 12030961.
      Citations: 95     Fields:    Translation:Humans
    606. El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002 Jun; 122(7):1822-8. PMID: 12055590.
      Citations: 39     Fields:    Translation:Humans
    607. el-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002 Jun; 31(2):421-40, viii. PMID: 12134611.
      Citations: 41     Fields:    Translation:HumansPHPublic Health
    608. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002 Mar; 50(3):368-72. PMID: 11839716; PMCID: PMC1773122.
      Citations: 79     Fields:    Translation:Humans
    609. Mallat DB, El-Serag HB. Interferon: benefit beyond hepatitis therapy? Am J Gastroenterol. 2001 Dec; 96(12):3435-6. PMID: 11774964.
      Citations: 1     Fields:    Translation:Humans
    610. El-Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology. 2001 Dec; 121(6):1294-9. PMID: 11729108.
      Citations: 44     Fields:    Translation:Humans
    611. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001 Aug; 96(8):2462-7. PMID: 11513191.
      Citations: 71     Fields:    Translation:Humans
    612. Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001 Aug; 33(2):123-6. PMID: 11468438.
      Citations: 30     Fields:    Translation:Humans
    613. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001 Jul; 96(7):2013-8. PMID: 11467626.
      Citations: 29     Fields:    Translation:Humans
    614. Hampel H, Bynum GD, Zamora E, El-Serag HB. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001 Jul; 96(7):2206-10. PMID: 11467654.
      Citations: 33     Fields:    Translation:Humans
    615. El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001 Apr; 96(4):979-83. PMID: 11316215.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    616. el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001 Feb; 5(1):87-107, vi. PMID: 11218921.
      Citations: 76     Fields:    Translation:Humans
    617. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001 Jan; 33(1):62-5. PMID: 11124821.
      Citations: 97     Fields:    Translation:Humans
    618. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000 Dec; 95(12):3566-73. PMID: 11151893.
      Citations: 48     Fields:    Translation:Humans
    619. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000 Nov 27; 160(21):3227-30. PMID: 11088082.
      Citations: 109     Fields:    Translation:Humans
    620. El-Serag HB. Segment length and risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000 Nov 07; 133(9):747-8. PMID: 11074916.
      Citations:    Fields:    Translation:Humans
    621. El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000 Feb 15; 132(4):261-9. PMID: 10681280.
      Citations: 9     Fields:    Translation:Humans
    622. El-Serag HB. Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol. 1999 Dec; 94(12):3395-6. PMID: 10606286.
      Citations:    Fields:    Translation:Humans
    623. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut. 1999 Aug; 45(2):181-5. PMID: 10403728; PMCID: PMC1727606.
      Citations: 30     Fields:    Translation:HumansCells
    624. El-Serag HB, Sonnenberg A. Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol. 1999 Jul; 94(7):1771-6. PMID: 10406233.
      Citations: 5     Fields:    Translation:Humans
    625. Delcò F, El-Serag HB, Sonnenberg A, Delc? F. Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci. 1999 May; 44(5):966-72. PMID: 10235605.
      Citations: 13     Fields:    Translation:Humans
    626. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11; 340(10):745-50. PMID: 10072408.
      Citations: 754     Fields:    Translation:Humans
    627. El-Serag HB, Sonnenberg A. Ethnic variations in the occurrence of gastroesophageal cancers. J Clin Gastroenterol. 1999 Mar; 28(2):135-9. PMID: 10078821.
      Citations: 7     Fields:    Translation:Humans
    628. El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol. 1999 Mar; 94(3):622-7. PMID: 10086641.
      Citations: 15     Fields:    Translation:Humans
    629. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med. 1999 Mar-Jun; 72(2-3):81-92. PMID: 10780569; PMCID: PMC2579001.
      Citations: 22     Fields:    Translation:HumansCells
    630. El-Serag HB, Johnston DE. Carbamazepine-associated severe bile duct injury. Am J Gastroenterol. 1999 Feb; 94(2):526-7. PMID: 10022661.
      Citations:    Fields:    Translation:Humans
    631. el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998 Sep; 43(3):327-33. PMID: 9863476; PMCID: PMC1727258.
      Citations: 84     Fields:    Translation:Humans
    632. Sonnenberg A, Delcò F, El-Serag HB, Delc? F. Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998 May; 43(5):1001-8. PMID: 9590414.
      Citations: 6     Fields:    Translation:Humans
    633. el-Serag HB, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut. 1997 Nov; 41(5):594-9. PMID: 9414963; PMCID: PMC1891561.
      Citations: 33     Fields:    Translation:Humans
    634. El-Serag HB, Johnston DE. Mycobacterium avium complex esophagitis. Am J Gastroenterol. 1997 Sep; 92(9):1561-3. PMID: 9317090.
      Citations:    Fields:    Translation:HumansCells
    635. el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997 Sep; 113(3):755-60. PMID: 9287965.
      Citations: 66     Fields:    Translation:Humans
    636. Sonnenberg A, El-Serag HB. Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin N Am. 1997 Jan; 7(1):165-84. PMID: 8995120.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    637. El-Serag HB, Sonnenberg A. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 1997 Jan; 92(1):52-6. PMID: 8995937.
      Citations: 11     Fields:    Translation:Humans
    638. El-Serag HB, Zwas F, Bonheim NA, Cirillo NW, Appel G, El-Serag HB. The renal and urologic complications of inflammatory bowel disease. Inflamm Bowel Dis. 1997; 3(3):217-24. PMID: 23282807.
      Citations:    
    639. Zwas FR, Cirillo NW, el-Serag HB, Eisen RN. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc. 1996 May; 43(5):463-6. PMID: 8726758.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    640. el-Serag HB, Zwas FR, Cirillo NW, Eisen RN. Fulminant herpes colitis in a patient with Crohn's disease. J Clin Gastroenterol. 1996 Apr; 22(3):220-3. PMID: 8724263.
      Citations: 9     Fields:    Translation:Humans
    EL-SERAG's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (936)
    Explore
    _
    Co-Authors (137)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _